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Abstract 
 
Mass spectrometry is widely applied to characterize oligo- and poly-nucleotides, 
peptides, and proteins.  In tandem mass spectrometry (MS/MS), analytes are dissociated 
in the gas phase and their fragments are analyzed to generate structural information.  
Among the various MS/MS techniques, few are well suited for acidic biomolecules, 
particularly nucleic acids and acidic peptides/proteins.   
In this dissertation emerging MS/MS methods are applied to new problems and to 
molecules not previously studied by such techniques.  Gas-phase fragmentation of 
peptide nucleic acid (PNA) cations and anions was examined in collision activated 
dissociation (CAD), infrared multiphoton dissociation (IRMPD), electron capture  
dissociation (ECD), and electron detachment dissociation (EDD).  Negative-ion CAD and 
IRMPD provided the most sequence information and were simplest to interpret.  Positive-
ion mode MS3 and double resonance experiments revealed mechanistic details on the 
water loss pathway.  N-terminal acetylation blocked this pathway and simplified 
spectrum interpretation.  A 27-mer ribonucleic acid (RNA) and its complexes with 
aminoglycoside antibiotics were characterized by ion-mobility MS, negative-ion CAD, 
and EDD.  Higher binding specificity and lower gas-phase charge state were correlated 
with a more compact RNA structure.  EDD fragmentation efficiency was higher for 
higher charge states. Negative-ion IRMPD and EDD were compared to positive-ion 
xx 
 
IRMPD and ECD for dissociating intact proteins.  For acidic proteins, negative ion mode 
techniques provided complementary sequence information to positive ion mode. 
Negative-ion ECD (niECD) was investigated for oligonucleotide characterization.  
Activated ion-niECD and niECD-IRMPD MS3 provided similar fragmentation patterns 
as EDD, possibly due to similar gas-phase precursor ion structures.  Characteristic “ECD-
like” radical fragments also suggested similarities to ECD, which may be due to 
DNA/RNA zwitterionic structures in negative ion mode. 
Proton transfer reaction (PTR) was performed prior to niECD of phosphopeptides.  
For peptides larger than 1700 Da, PTR reduced the ion accumulation time and increased 
the detection efficiency of niECD fragments.  niECD was also coupled to offline nano-
LC by segmented flow fraction collection, which allowed more time for signal averaging, 
compared with online LC coupling. 
Overall this dissertation presents method development for improved MS/MS 
analysis in systems biology, i.e., the study of organisms as a whole rather than focusing 
on individual biochemical pathways. 
1 
 
Chapter 1 
 
Introduction 
 
1.1 Characterization of Peptides/Proteins with Mass Spectrometry 
The proteome,1, 2 in analogy with the genome, is the collection of all proteins 
present in an organism, cell, or system.  Proteomics, an analog to genomics, aim to 
investigate the whole spectrum of proteins, including their identities, quantities, 
modifications, interactions, and functions to understand a biological system.  The 
challenges for researchers lie in the qualitative and quantitative complexity of the 
proteome.  As revealed by the Human Genome Project, the human genome encodes 
20,000-25,000 protein-coding genes.3  However, post-translational modifications (PTMs) 
are commonly observed.  According to the Universal Protein Resource (UniProt, a well 
established online protein database), 434 different PTMs have been reported.4  Also, 
protein-protein and protein-ligand interactions dramatically increase the qualitative 
complexity.  It has been estimated by statistical methods that around 650,000 protein-
protein interactions are possible in humans.5  Quantitative investigation is also 
challenging due to the requirement of high sensitivity and dynamic range.  The 
abundance of a protein is affected by its expression level, PTM level, conditions within 
the cell or the organism, biological activities and so on.  Due to these complexities, 
2 
 
technologies for studying proteomics should be able to detect, identify, and quantify 
proteins with high sensitivity, specificity, and efficiency.  Proteomics combines 
techniques from biology, biochemistry, chemistry, biophysics, bioinformatics, biomedical 
engineering, chemical engineering, and other disciplines.  
Mass spectrometry is one powerful technology contributing to current proteomics.  
State-of-the-art mass spectrometers, along with other tools, provide high sensitivity, high 
specificity, and high through-put.6, 7  Peptides can be detected at low attomole8, 9 or even 
zeptomole10 amounts.  Mass accuracy at the hundreds of parts-per-billion (ppb) level has 
been achieved.11  From coupling with separation techniques, around 1000 proteins can be 
identified in one hour.12 
There are two complementary approaches for protein analysis by mass 
spectrometry: bottom-up and top-down analysis, as shown in Figure 1.1.13  These two 
approaches are discussed in the following sections. 
3 
 
 
Figure 1.1.  Systematic overview of bottom-up and top-down mass spectrometry for 
dissecting the primary structure of proteins.  Adapted from Chait.13 
1.1.1 Bottom-up Approach of Proteomics 
Bottom-up mass spectrometry for proteomics is widely applied for protein 
identification, quantification, PTM analysis, and structural analysis.  The sample is a 
collection of proteins of interest, ranging from one particular protein to a whole cell 
lysate or tissue extract.  The collection of proteins is digested by proteases such as trypsin 
to generate a pool of peptides.  Then the peptides are analyzed by mass spectrometry.  By 
piecing back the identified peptides, facilitated by bioinformatics tools and appropriate 
databases, primary structure of proteins can be identified.  
4 
 
Several techniques are closely associated with mass spectrometry in bottom-up 
proteomics.  Various separation techniques, such as liquid chromatography (LC), 
capillary electrophoresis (CE), and gel electrophoresis, play important roles in the 
workflow.  Their ability to fractionate proteins or peptides according to various physical 
and chemical properties reduces sample complexity.  More proteins/peptides can be 
identified due to the increased peak capacity of the combined separation-MS workflow.14  
For example, a 12T Fourier transform ion cyclotron resonance (FT-ICR) mass 
spectrometer can offer a peak capacity of ~25,000 for peptides,15 while ultrahigh-pressure 
liquid chromatography (UHPLC) offers peak capacity of 1500.16  It has been estimated 
that coupling reversed-phase (RP) HPLC to FT-ICR-MS provides an additional two 
orders of magnitude increase in peak capacity, and further coupling of strong cation 
exchange (SCX) fractionation provides another order of magnitude increase.15  Two-
dimensional (2-D) gel electrophoresis also has been widely demonstrated to separate 
proteins from a whole proteome.1  Similar to 2-D liquid chromatography, the two 
separation methods should be orthogonal, i.e., based on different properties of proteins, 
such as size and isoelectric point (pI).  2D electrophoresis is capable of separating 
thousands of proteins and compatible with mass spectrometry through in-gel digestion.17  
However, compared to LC-MS this approach is labor intensive and low-throughput. 
With the development of bioinformatics tools, the bottom-up approach is widely 
used for identifying proteins.  One data set from an LC-MS/MS run in large-scale 
proteomics can contain tens of thousands of spectra.  Fully manual interpretation is not 
feasible and thus computerized data searching tools such as Mascot18 and SEQUEST,19 as 
well as other specialized software, compare the experimental data to public or custom-
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built databases.  By balancing between sensitivity and specificity, automated data 
interpretation can yield acceptable results.20  
Protein quantification by mass spectrometry is also achievable.  Due to the fact 
that mass spectral ion abundances are not directly correlated to protein concentration, 
some forms of internal standards or references are required.  Absolute and relative 
quantification can be achieved by labeling techniques such as isotope-coded affinity tags 
(ICAT),21 stable isotope labeling with amino acids in cell culture (SILAC),22 and isobaric 
tagging,23 or by label-free techniques such as spectral counting.24 
Structural analysis by bottom-up approach is available through chemical 
crosslinking methods.25  The idea is to covalently link two amino acid residues in spatial 
proximity.26  From protease digestion and identification of crosslinked peptides, a map of 
protein intramolecular interactions or protein-protein interactions can be built.27  
Chemical crosslinkers can be designed to fit particular applications.  Crosslinkers with 
different lengths probe distance between two interacting amino acids whereas 
crosslinkers with different reactive end groups can probe different types of interacting 
amino acids.  Crosslinkers with chemically enrichable motifs or mass spectrometric 
signature motifs can enhance the detection of crosslinked peptides. 
The bottom-up approach, compared with the top-down approach, offers several 
advantages:  Peptides in general, compared to proteins, are easier to dissolve in water, are 
more stable, and have higher ionization efficiency.  The bottom-up approach is also 
considered high throughput in large-scale proteomics.  However, typically not all 
peptides from one protein are detected.  Also, one peptide can originate from different 
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proteins.  Therefore the correlation from peptides back to proteins can be problematic and 
requires support from bioinformatics tools.13  
1.1.2 Top-down Approach of Proteomics 
Top-down mass spectrometry for proteomics is applied for protein identification, 
PTM analysis, structural analysis, protein-protein interaction analysis, and protein-ligand 
analysis.  In the top-down approach, intact proteins are introduced to the gas phase 
without protease digestion and their intact mass is measured.  Tandem mass 
spectrometric techniques allow protein ions to be fragmented.  Based on the fragment 
masses, protein primary structure can be obtained facilitated by bioinformatics tools and 
appropriate databases.  Electron capture dissociation (ECD)28 and electron transfer 
dissociation (ETD)29 benefit top-down mass spectrometry based on their ability to 
dissociate the protein backbone more randomly than collision activated dissociation 
(CAD) and their ability to retain labile PTMs.  PTMs can thus be directly located.30, 31  
Protein structure can also be probed by hydrogen/deuterium exchange (HDX)32-34 or 
ECD.35  The top-down approach is able to directly detect and localize PTMs.  It is also 
able to directly characterize protein-protein and protein-ligand complexes.  However, 
relatively low throughput is a major disadvantage, as the sample is required to be 
relatively pure and abundant. 
1.2 Characterization of Nucleic Acids with Mass Spectrometry 
The genome is the collection of an organism’s hereditary information.  This 
information is encoded in the form of deoxyribonucleic acids (DNAs) and ribonucleic 
acids (RNAs).  Genomics aims to investigate the genome in terms of sequences, 
7 
 
structures, interactions, and functions.  Many tools from biology, chemistry, physics, 
engineering, and informatics have been developed for genomics studies, such as DNA 
sequencing technology invented by Nobel laureate Frederic Sanger in 1977.36  Direct 
analysis of intact oligo- and poly-nucleotides by mass spectrometry has been limited by 
the ionization techniques.  Nucleic acids are highly polar and difficult to volatilize.37  
Also, the glycosidic bonds in nucleotides are labile and readily cleaved if the ionization 
process is not soft enough.38  The introduction of “soft” ionization techniques such as 
matrix-assisted laser desorption/ionization (MALDI)39, 40 and electrospray ionization 
(ESI)41 greatly extended the application of mass spectrometry to genomics, due to their 
abilities to ionize polynucleotides efficiently without fragmentation.  
Fast atom bombardment (FAB), before ESI and MALDI, was applied to ionize 
oligonucleotides, and was demonstrated to generate intact molecular ions along with 
series of fragment ions.42, 43  However, in practice, FAB is only able to provide molecular 
ions up to 10-mers, and the overall sensitivity is low.44 
MALDI was shown to ionize intact oligonucleotides soon after its invention,45 
including successful ionization of large nucleic acids such as tRNAs.46  Compared with 
ESI, MALDI is advantageous due to the tolerance of sample interferences such as salt 
and also its high sensitivity.38  However, MALDI typically generates singly charged ions 
and the upper mass limit is thus determined by the m/z range of the mass spectrometer.  
Multiple charging offered by ESI brings m/z ratios of large molecules down to the 
detection range of most common mass spectrometers.  Also, some tandem mass 
spectrometric techniques, such as electron detachment dissociation (EDD), require 
multiply charged precursor ions.  
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ESI is able to ionize large polynucleotides such as tRNA47 and DNA PCR 
products48, 49 in intact form.  Isotopic distributions of intact nucleic acid ions can be 
resolved by mass analyzers with high resolving power such as FT-ICR and intact mass 
can be determined accurately within ppm range.  In addition to intact mass measurements, 
nucleic acid ions can be fragmented in the gas phase.  Vibrational activation such as CAD 
and infrared multiphoton dissociation (IRMPD),50, 51 as well as ion-electron reactions 
such as ECD52 and EDD53 have been applied to generate backbone fragments.  Sequence 
information can be retrieved from the fragment ion series.  Nucleic acid complexes such 
as duplexes,54-57 oligonucleotide-ligand complexes,58-61 and RNA-protein complexes62, 63 
can also be identified and characterized.  Combined with gas-phase H/D exchange, gas-
phase structure of nucleic acids can be accessed.64-66  In addition to the advantage of 
multiple charging, ESI is considered “softer” than MALDI.  In MALDI metastable decay 
has been observed between the ionization and detection events,67 whereas non-covalent 
complexes can be preserved from ESI.  Despite these advantages, ESI is less tolerant to 
salts than MALDI.  Nucleic acids are hydrophilic and highly negatively charged, thus 
having high affinity to metal ions such as sodium and potassium.  When samples are not 
treated with proper desalting procedures, spectra can be complicated by adducts with 
various numbers of metals, which also lowers sensitivity.  This problem may be reduced 
by precipitation from ammonium acetate and organic additives.68 
1.3 Fourier Transform Ion Cyclotron Resonance Mass Spectrometry 
1.3.1 Basic Concepts 
Early ideas on measuring mass-to-charge (or charge-to-mass) ratios from ion 
cyclotron resonance frequencies in a magnetic field emerged in the 1940s and 1950s.69, 70  
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The first realization of this concept was the measurement of the proton charge-to-mass 
ratio by Sommer and Hipple in 1951.71  FT-ICR-MS was first introduced by Comisarow 
and Marshall in 1974.72, 73  Since its invention, FT-ICR-MS has been extensively studied, 
developed, and applied.  The FT-ICR mass analyzer is the most powerful type of mass 
spectrometer in terms of mass accuracy and resolution.  The development of “soft” 
ionization techniques such as ESI and MALDI, allowed FT-ICR-MS to be extensively 
applied for analysis of  biomacromolecules such as proteins/peptides  and nucleic acids.  
FT-ICR-MS is based on the cyclotron motion of an ion in a highly homogenous 
magnetic field, usually provided by superconducting magnets.  When an ion with mass m, 
charge q = ze in which e is the elementary charge and z is the number of elementary 
charges, and velocity v is placed into a magnetic field B, it experiences the Lorentz force 
with a magnitude of F = zevB and a direction perpendicular to v and B, as described in 
equation 1.  This force is a centripetal force and can also be expressed as in equation (2).    
Combination of equations (1) and (2) leads to an expression for the angular frequency, v/r 
or ω, of the cyclotron motion driven by the Lorentz force as shown in equation (3).  If B 
is known, the mass-to-charge ratio can be determined by measuring ω.  In other words, 
each ion with a specific m/z ratio has a characteristic frequency in a given magnetic field. 
F = zev × B  (1) 
r
vmF
2
=
  (2)
 
m
zeB=ω   (3) 
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The key component of an FT-ICR mass spectrometer is the ICR cell.  There are 
several ICR cell geometries, such as cubic traps, cylindrical traps, and hyperbolic traps74 
and also various modified geometries for better performance.  Despite this variety, 
common ICR cells consist of three basic components: trapping electrodes, excitation 
electrodes, and detection electrodes. 
  When ions are transferred along the axial direction (z-direction) into the ICR cell, 
trapping plates with small (~1 V) DC potentials prevent ions from escaping the cell 
axially.  Ideally, ions are oscillating axially in a one-dimensional potential well.75 
The initial ion radial velocity typically generates cyclotron motion with a radius 
much smaller (~1 mm) than the radius of the cell (~10 cm).  A modulated waveform, or 
“chirp”, serving two purposes, is applied to the excitation electrodes.  The first function 
of the chirp, which contains the frequencies of all ions within the m/z range of interest, is 
to cause absorption of energy by ions in resonance with the applied frequencies and thus 
increase their cyclotron radii.  Second, the initial phases of the ion cyclotron motions are 
random but the excitation waveform, with a specific phase, synchronizes the phases of all 
ions and forces ions with the same m/z ratio into one compact ion packet.  
After ions are excited and their ion cyclotron radii are close to the detection 
electrodes, the movement of the ion packets induces a local electric field change on the 
surface of the detection electrodes.  The corresponding image current, flowing from one 
detection electrode to the other is recorded.  At least about 100 charges of a given m/z are 
needed to induce a detectable current.76  Compared with other detectors in other types of 
mass spectrometers, such as electron multipliers with a gain of 107,77 the ICR detection 
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principle has lower sensitivity.  However, ICR detectors are non-destructive and ion 
packets can be remeasured.   The measured image current is digitized and stored as a 
time-domain signal.  Through fast Fourier transform, time-domain signal is converted to 
frequency-domain signal.  Frequencies are then converted to m/z ratios based on equation 
(3).  The longer the image current is recorded, the better resolution the mass spectrum 
has.78 
A schematic view of FT-ICR detection is shown in Figure 1.2.79 
 
 
Figure 1.2 (Upper panel) Schematic diagram of an FT-ICR detector and the excitation of 
an ion. (Lower panel) (a) The time-domain signal of ubiquitin ions recorded by image 
current detection. (b) Frequency domain signal from the time-domain signal through fast 
Fourier transformation. (c) Mass spectrum from calibration of the frequency domain 
signal. 
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The Orbitrap80, 81 is a mass analyzer based on the Kingdon trap developed in 
1923.82  Similar to the detection principle in FT-ICR, Orbitrap ion detection is also based 
on image current and Fourier transformation.  However, ion motion is confined by a 
combined quadro-logarithmic electrostatic field, instead of the homogeneous magnetic 
field in FT-ICR-MS.  The geometry of an Orbitrap detector consists of an inner spine-like 
central electrode and an outer barrel-like electrode.  The shape of these electrodes 
determines the shape of the electric field.  Trapped ions move harmonically along the 
axis and also orbit the inner electrode radially.  Mass-to-charge ratio is derived from the 
frequency of axial motion.  Orbitrap mass spectrometers provide higher mass accuracy 
than other mass spectrometers, except for FT-ICR-MS and high performance time-of-
flight (TOF) mass spectrometers. 
1.3.2 Factors Affecting FT-ICR Detection Performance and Solutions for 
Improvement 
 
There are several factors making the performance of FT-ICR detection deviate 
from the ideal case.  
Magnetron motion of ion packets is induced by the combination of the trapping 
electric field and the magnetic field.  The magnetron frequency is one to three orders of 
magnitude smaller than the cyclotron frequency.74  The observed image current frequency 
corresponds to the difference between the ion cyclotron frequency and the magnetron 
frequency.  In practice, to first order approximation, the observed frequency can be 
expressed as shown in Equation 4. 
2/ f
B
f
Azm +=  (4) 
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The constants A and B are experimentally determined by fitting observed 
frequencies for known m/z ratios to Equation 4.  The magnitude of the magnetron motion 
is dependent on the trapping potential.  Due to the fact that the electric field induced by 
the trapping voltages is not uniform in space, the magnitude of magnetron motion is 
dependent on the ion position.  The magnitude variation of the magnetron motion induces 
peak broadening.  Ways to improve the uniformity of the trapping potential include, e.g., 
addition of rf-shimming wires,83 addition of compensation electrodes,84, 85 and reshaping 
of excitation/detection electrodes.86  Collisional damping combined with magnetron 
motion may be detrimental to resolution and calibration.  Ideally ICR cells should be 
operated under absolute vacuum to maximize image current duration.  In practice ICR 
cells are under ultra high vacuum (<10-9 mBar range).  However, due to the high ion 
velocity, collisions with neutral gas molecules still occur, resulting in partial loss of both 
radial and axial velocity, and thus magnetron motion at varying magnitude.  If the 
magnetron motion is not constant within an image current transient, mass spectral 
resolution and calibration will deteriorate. 
Space-charge effects are also affecting spectral resolution.  Due to Coulomb 
repulsion, ion packets expand after the excitation stage.  Increased ion packet sizes 
broaden observed frequency distributions, increase mass spectral peak widths, induce 
peak splitting, and even generate artificial peaks.87  Ideally, few ions should be allowed 
into the ICR cell for optimum resolution.  In practice, automatic gain control (AGC)88 can 
be used to balance resolution and sensitivity. 
Harmonic signals are observed as artificial peaks in image current detection.  
Given that the ion cyclotron frequency at one m/z ratio is ωc, odd harmonic frequencies at 
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3ωc, 5ωc, etc. are commonly observed.  Odd harmonics mainly arise from the 
discontinuous image current recorded from the detection electrode pair, due to the gap 
between the two detection electrodes.  Optimizing the span of detection/excitation 
electrodes helps reduce the odd harmonics, particularly for the third harmonic.89  Even 
harmonics are also observed but of less abundance compared to odd harmonics.  Even 
harmonics arise from off-axis ions74 and also from a mismatch in the two channels of the 
detection circuit.90  Even harmonics can be reduced by summing time-domain signals at 
integer powers of 2, i.e., setting the scan number to 2, 4, 8, etc.  
Artificial peaks at roughly 1 Da to the side of an abundant isotope cluster are 
observed, due to overloading of the analog-to-digital converter (ADC) for converting 
analog time-domain image current to discrete signal for computer input, as demonstrated 
in Figure 1.3.90  Implementation of automatic-gain control, which controls the number of 
ions in the ICR cell, helps minimize this effect. 
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Figure 1.3.  (a) Simulated transient of C60 signal with asymmetric overloading of the 
ADC.  (b) Simulated mass spectrum with 1 Da spacing artifacts due to intermodulation of 
the C60 isotope signals. 
1.3.3 Instrumentation 
A schematic diagram of a commercial FT-ICR mass spectrometer is shown in Figure 1.4. 
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Figure 1.4. Configuration of a commercial 7-T Q-FT-ICR mass spectrometer. 
Basic components include an electrospray ionization source, a quadrupole (Q), a 
hexapole (collision cell), ion optics, and the ICR cell.  The ESI source principles are 
discussed in section 1.2 below.  The quadrupole can be used to allow only ions within a 
certain m/z window to pass.  The hexapole collision cell is used for external 
accumulation of ions, and for performing gas-phase reactions such as CAD, electron 
transfer dissociation (ETD), and hydrogen-deuterium exchange.  Transfer optics is used 
to transport ions through the magnetic field gradient into the ICR cell.  Inside the ICR 
cell ions can be subjected to activation such as sustained off-resonance irradiation (SORI) 
CAD, IRMPD, ECD, and EDD.  These tandem mass spectrometric techniques are 
discussed in detail in the following sections.  The ICR cell is also used for ion excitation 
and detection, as described in the previous section. 
1.4 Electrospray Ionization (ESI) 
1.4.1 Principle and Implementation 
17 
 
Mass spectrometry measures mass-to-charge ratio in the gas phase.  However, 
most biomolecules are soluble in aqueous phase and not volatile.  Ionization techniques 
are necessary to bring biomolecules from solution phase to the gas phase, while 
preserving the native structure as much as possible.  ESI41 and MALDI40, 91 are typical 
“soft” ionization methods.  Through ESI, large biomolecules and even non-covalent 
complexes can be brought into the gas phase in intact form.92  
Figure 1.5 shows a typical ESI apparatus. 
 
Figure 1.5. Schematic description of ESI.93 
During positive ion mode ESI, in which analytes typically carry positive charge in 
solution, a solution containing analytes is forced through a needle-shaped tip.  The 
solution near the tip is connected to a highly positive voltage, usually several thousand 
volts.  Due to the repulsion between positively charged species and due to the electric 
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field gradient, bulk solution exiting the emitter overcomes the surface tension, forms a 
Taylor cone,94 and breaks into positively charged droplets.  Negative charges move 
towards the inner wall of the emitter and are neutralized.  Excessive negative charges 
(electrons) flow to the power supply circuit.  Positively charged droplets fly towards the 
inlet of the mass spectrometer driven by the electric field and the pressure gradient.  With 
the help of heated drying gas or a heated inlet, droplets desolvate and shrink.  When 
Coulomb repulsion between charges on the surface of a droplet exceeds the surface 
tension (Rayleigh charge limit95-97), the droplet splits into smaller droplets.  Eventually 
solvent completely evaporates and the charge carrying non-volatile species from the 
original spray solution are collected by the inlet of the mass spectrometer.  
The mechanism behind ion generation in ESI is debated.98, 99  There are two main 
models: the ion evaporation model100 and the charged residue model.101  According to the 
ion evaporation model, charges are distributed primarily on the droplet surfaces and 
analyte ions on the surface may be ejected from the droplet into the gas phase due to field 
desorption.  The charged residue model states that non-volatile species remain inside the 
droplets during the repetitive Coulomb fission process.  The non-volatile species are then 
forced to carry charges in the gas phase when solvent is completely evaporated.  
If the spray solution contains water, hydrophobic analytes are distributed more on 
the surface of the droplets due to solubility.102  Hydrophilic molecules prefer the center of 
the droplets and have less chance to be ejected out of the droplets, and thus lower 
ionization efficiency is observed for such species.103 
1.4.2 Characteristics of ESI 
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First, ESI is considered to be a “soft” ionization technique preserving the native 
structure of analytes.  It has been shown to preserve not only covalent bonds but also 
non-covalent bonds, such as large protein-protein complexes104 and DNA duplexes.54  
The “soft” nature mainly comes from the fact that most ionization energy is dispersed by 
solvent evaporation before analyte decomposition occurs41 and there is no sudden energy 
change for the analyte molecules during the ESI process. 
Second, ESI offers multiple charging.  Multiple charging brings the m/z ratio of 
large molecules below the upper m/z limit thus making detection of large molecules 
possible, for example, whole TMV virus at 39-42 MDa.105  Multiple charging also 
enhances the signal abundance in FT-ICR-MS, as the image current is directly 
proportional to the number of charges on the analyte ion.  For tandem MS (MS/MS), 
multiple charging of precursor ions often improves fragmentation efficiency.29, 106-108 
1.5 Tandem Mass Spectrometry (MS/MS, MSn) 
Measuring accurate masses helps identify analytes.  However, due to the presence 
of isomers, in many cases mass alone cannot confirm the identity of an analyte.  Also, 
information regarding the primary structures of analytes is of interest in many cases.  In 
tandem mass spectrometry, ions of a selected m/z ratio are fragmented in the mass 
spectrometer.  Based on the fragmentation chemistry of a particular MS/MS activation 
method and the fragments observed, additional structural information can be obtained. 
Depending on the application, the desired MS/MS fragmentation pattern varies.  
In order to obtain sequence information for biomolecules composed of similar building 
blocks, the appropriate MS/MS technique should generate cleavages between each 
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building block specifically.  For example, for a peptide, the proper MS/MS technique 
should be able to provide cleavages between each amino acid.  In order to probe a certain 
property of a molecule, MS/MS should be able to provide specific information regarding 
that property.  For example, in order to examine if a peptide contains phosphorylated 
serine or threonine, the MS/MS technique should generate cleavages directly related to 
the phosphate. 
Among various tandem mass spectrometric activation techniques, there are two 
common classes: vibrational activation and radical-driven reactions.  Vibrational 
activation includes, e.g., CAD109 or collision-induced dissociation (CID), IRMPD,110, 111 
blackbody infrared radiative dissociation (BIRD),112, 113 nozzle-skimmer 
fragmentation,114 and multipole storage assisted dissociation (MSAD).115, 116  Ion-electron 
reactions include ECD,28 EDD,117 hot ECD,118 electron-induced dissociation (EID),119, 120 
and negative ion electron capture dissociation (niECD).121  Ion-ion reactions include 
ETD29 and negative electron transfer dissociation (NETD).122  There are many other 
types of tandem mass spectrometric activation techniques widely studied and applied, e.g., 
ultraviolet photodissociation (UPVD).123  CAD, IRMPD, ECD, EDD, and niECD are 
discussed in the following sections. 
1.5.1 Precursor Ion Selection 
MS/MS can be performed on ions of various m/z ratios or, more commonly, one 
particular m/z of interest.  In the latter case, a precursor ion selection step prior to 
activation/dissociation is required.  Precursor ion selection can be implemented in a 
variety of ways:  
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In the FT-ICR cell, precursor ion selection can be achieved by stored waveform 
inverse Fourier transform (SWIFT).124, 125  In this method, a frequency domain waveform 
including frequencies corresponding to all unwanted m/z ratios is computed.  Then this 
frequency domain waveform is inversely Fourier transformed to a time domain waveform.  
The stored time domain waveform is applied to one pair of ICR cell electrodes,126 
resulting in excitation of ions with cyclotron frequencies included in the applied 
waveform, similar to the excitation step preceding ICR detection.  However, ions are 
excited to a greater extent to reach the electrodes and be neutralized.  In theory ions with 
cyclotron frequencies not included in the waveform are not affected.  
A quadrupole mass filter can also be used as a mass-selecting device.127  In mass-
resolving mode, an RF and DC combined potential is applied to the two pairs of rod 
electrodes.  This potential defines an m/z window outside of which ions cannot undergo 
stable oscillatory motion between the rods, and thus will be ejected radially.  Only ions 
with m/z ratios within the defined window can migrate through the quadrupole.  A 
quadrupole coupled with an FT-ICR mass analyzer can function as an external mass 
filter.128  Similar to a linear quadrupole, a quadrupole ion trap can also be used for 
external mass selection.129 
1.5.2 Tandem Mass Spectrometry in Time or in Space 
In tandem in time mass spectrometry, precursor ion selection and 
activation/fragmentation are performed in the same space but sequential in time.  Thus 
the cycle of selection/fragmentation can continue until ion abundance is below the 
detection limit, meaning that the number of cycles is limited by the starting ion 
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abundance.  In other words, MSn is possible where n can be a fairly large number.  
However, in practice n can be 4130, 131 or 5132 for an ICR cell, and as large as 10133, 134 for 
an ion trap. 
In tandem in space mass spectrometry, precursor ion selection and 
activation/fragmentation are performed sequentially with different mass analyzers.  For 
example, in the configuration shown in Figure 1.4, a hexapole is located between the 
quadrupole and the ICR cell.  This hexapole functions as an external device for gas-phase 
reactions and collisional activation of mass-selected ion.  Fragments from CAD are 
transferred to the ICR cell for detection.   
1.5.3 Collision Activated Dissociation (CAD) 
CAD or CID is a widely used technique for fragmenting gaseous ions.  The basic 
process involves inelastic collisions between accelerated ions and neutral molecules such 
as argon.  Depending on the kinetic energy of the accelerated ions, there are two types of 
CAD: high energy CAD in the kilo eV range and low energy CAD in the 1-100 eV range.  
High energy CAD, which mainly causes  electronic  excitation,135 can be performed in 
tandem sector instruments and TOF/TOF-type instruments.  Low energy CAD can be 
performed in multipoles, FT-ICR cell, ion trap, and ion sources close to ambient pressure.  
Low energy CAD excitation is mostly vibrational.136  In this thesis, the acronym “CAD” 
refers to low energy CAD.  During the low energy CAD activation process, each inelastic 
collision deposits a small amount of internal energy into the precursor ion.  However, the 
energy from each collision is not sufficient to break a chemical bond but, after multiple 
collisions, the accumulated energy is high enough to cause bond cleavage.  For this 
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reason, CAD is considered one of the “slow-heating” techniques.  During collisional 
activation, the internal energy is redistributed through intramolecular vibrational-energy 
redistribution (IVR)137.  Thus, in general, CAD and other slow-heating techniques tend to 
cleave the most labile bonds in a molecule.  
There are several methods to implement CAD: 
 In beam-type CAD, precursor ions are accelerated by an electric field into a 
chamber filled with neutral gas.  In the configuration in Figure 1.4, the hexapole located 
in between the quadrupole and the ICR cell is filled with argon to a pressure of ~10-6 
mBar.  Precursor ions selected by the quadrupole are accelerated into the hexapole, 
collide with argon, and fragment.  The radial RF electric field confines fragments inside 
the hexapole.  Triple quadrupole and Q-TOF-type instruments also contain similar 
geometries for beam-type CAD.  
In ion trap-type CAD, precursor ions are accelerated by resonant excitation.  In 
3D ion trap-type instruments the RF amplitude is increased to axially excite precursor 
ions.  The excited precursor ions collide with the background helium gas and dissociate.  
One difference between beam-type CAD and ion trap-type CAD is the amount of energy 
imparted per collision.  In beam-type CAD a relatively high amount of energy is 
deposited per collision with an activation time of ~10-4 s.  However, in ion trap CAD 
relatively low energy is deposited per collision and the activation time is ~10-1 to 10-3 s, 
i.e., significantly slower than beam-type CAD.  Ion trap CAD shows higher favorability 
for cleavage of the most labile bonds due to the narrower energy distribution at lower 
collision energy.138 
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 SORI-CAD139 is a CAD implementation in FT-ICR cells.  Because the pressure 
in ICR cells (<10-9 mBar) is significantly lower than that in ion traps (~10-3 mBar) or 
multipoles (~10-6 mBar), neutral gas is pulsed in to the cell.  An excitation waveform 
with a frequency close (±~1 kHz) to the frequency of selected precursor ions is applied to 
the excitation electrodes.  Precursor ions partially absorb excitation energy and collide 
with neutral gas as their cyclotron radii increase.  However, the off-resonant nature of the 
excitation pulse causes precursor ions to be accelerated and decelerated in a periodic 
manner, thus generating product ions near the center of the ICR cell.79  By contrast, on-
resonance excitation only involves an acceleration step and energy uptake is therefore 
limited by the size of the ICR cell.  Also, product ions are formed off-axis in resonant 
CAD, which limits further fragmentation and lowers ICR resolution.140  Overall, SORI-
CAD is similar to ion trap type CAD whereas resonant CAD is more similar to beam-
type CAD (with the advantages and disadvantages stated above).  One disadvantage of 
performing CAD inside the ICR cell is that collision gas needs to be leaked in.  Thus, 
after a CAD event, several seconds are needed to restore high vacuum, which reduces the 
duty cycle.  If the high vacuum is not restored, collisional damping will be more 
significant and resolution is deteriorated. 
 CAD is widely used for structural analysis of peptides, proteins, and nucleic 
acids.  For unmodified peptides and proteins, CAD primarily provides cleavages at 
peptide amide bonds to form b and y-type ions141 (Schemes 1.1-1.2).  Neutral loss of 
small molecules such as water and ammonia also occurs.  
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Scheme 1.1.  Nomenclature for peptide/protein fragmentation.  Adapted from Roepstorff 
et al. 141 
 
Scheme 1.2.  Generation of b and y-type ions from CAD of peptides/proteins.79 
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For DNA, CAD provides primarily (a - base) and w-type ions,142, 143 as shown in 
Schemes 1.3143 and 1.4.79  
 
Scheme 1.3.  Nomenclature for oligonucleotide fragmentation.  Adapted from McLuckey, 
et al.143 
 
Scheme 1.4.  (a - base) and w-type ions from CAD of DNA.79 
1.5.4 Infrared Multiphoton Dissociation (IRMPD) 
IRMPD144 is another type of slow-heating tandem mass spectrometric technique.  
During IRMPD, precursor ions are trapped in the ICR cell and irradiated with an IR laser 
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beam.  Precursor ions absorb multiple photons to accumulate internal energy until they 
reach their dissociation threshold.  Infrared photons are typically provided by a 10.6 μm 
CO2 laser but can  also be provided from a free electron laser (FEL)145 or optical 
parametric oscillator (OPO)146, 147 systems.  IRMPD has also been implemented in an 
external hexapole148 and in quadrupole ion traps.149  However, the pressure in the external 
hexapole or ion trap is several orders of magnitude higher than the UHV inside an ICR 
cell.  Under high pressure vibrationally excited ions are cooled through collisions with 
buffer gas molecules.  Thus IRMPD in ion trap devices is not as efficient as in ICR cells.  
IRMPD has been applied to dissociate proteins/peptides111 and also 
oligonucleotides.51, 52, 150, 151  IRMPD provides similar fragmentation patterns to low 
energy CAD.  One advantage of IRMPD in ICR cells over SORI-CAD is that IRMPD 
does not require introduction of gas into the ICR cell.  Thus, no pumping stage is needed 
after each fragmentation event.  Second, collisional damping of the time-domain signal is 
not affected in IRMPD so resolution and calibration are not worsened. 
IR irradiation inside the ICR cell can also be used as an activation method rather 
than a dissociation method.  IR irradiation preferentially breaks the weakest bonds within 
a molecule, such as non-covalent interactions.152, 153  
1.5.5 Electron Capture Dissociation (ECD) 
ECD is an MS/MS technique based on gas-phase ion-electron reactions.  It was 
first applied to dissociate peptides/proteins.28  ECD is performed by irradiating multiply 
charged precursor cations with low energy (<1 eV) electrons.  Precursor cations capture 
electrons and form meta-stable radical intermediates that dissociate into fragments, as 
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shown in Scheme 1.5.  For larger molecules, IR activation prior to or after electron 
irradiation is required to improve dissociation efficiency.  Typically ECD is performed in 
ICR cells.  Ion traps can be modified to perform ECD.154, 155  However, such 
implementation is still challenging because electrons have masses well below the low-
mass cut-off of typical ion traps designed to trap molecular analytes. 
 
Scheme 1.5.  Fragmentation pathway in ECD. 
For peptides/proteins, ECD preferentially cleaves N-Cα bonds to produce c and 
z•-type ions,28 as shown in Scheme 1.6. 
 
Scheme 1.6. Fragments from peptide ECD: c and z•-type ions.79 
The mechanism of ECD is still under debate.  The “hot hydrogen” model2, 156, 157 
proposes that electron capture occurs at protonated sites (i.e., N-terminus or basic side 
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chains).  The proton is neutralized to hydrogen and migrates to a nearby backbone 
carbonyl.  The weakened backbone N-Cα bond dissociates to form c and z•-type ions.  
The “amide super base” model158, 159 proposes that electron capture occurs into the 
LUMO of the carbonyl double bond.  Ab initio calculations revealed that electron 
attachment and subsequent N-Cα bond cleavage are thermodynamically favored with a 
stabilizing Coulomb potential.159  In this model the amide backbone directly captures an 
electron, facilitated by positive charges in spatial proximity.  After electron capture the 
excited carbonyl double bond is highly basic (“superbase”) and attracts a proton, 
explaining the hydrogen transfer observed based on the fragment masses. 
ECD has been proposed to be a nonergodic process.2, 28, 157  However, the detailed 
mechanism is still under debate.  It has been stated that, in ECD of cytochrome c, 
dissociation of the radical intermediate generated by electron capture, is faster than 
unfolding via IVR and faster than hydrogen-deuterium scrambling.28  Compared with 
slow-heating activation approaches, ECD provides more extensive backbone 
cleavages.160-162  
The radical-driven nature of ECD also provides complementary backbone bond 
cleavages for peptides/proteins compared to slow-heating techniques.  For example, ECD 
frequently retains labile post-translational modifications (PTMs) such as 
phosphorylation,31, 163 sulfonation,164 and glycosylation165-167.  By contrast, PTMs are 
preferentially lost in slow-heating methods such as CAD and IRMPD.  This characteristic 
of ECD allows direct localization of PTM sites within peptides/proteins.  ECD has also 
been applied for characterizing the structure of intact proteins168 and protein 
complexes.169  ECD effectively cleaves backbone amine bonds but does not disrupt non-
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covalent bonds.  Gas-phase protein structure contains intramolecular non-covalent 
interactions such as charge-charge interactions and hydrogen bonding.  Thus, fragments 
from ECD may still be connected with non-covalent bonds such that the total mass does 
not charge.  To observe ECD of proteins, additional activation, e.g., IR irradiation, is 
often required.  Consequently, ECD of proteins without additional activation may result 
in low fragmentation efficiency, which could be improved by additional activation such 
as IR irradiation or collisional activation.170-172 
Nucleic acids contain an acidic phosphate backbone and have an overall pI around 
2.  Unless the electrospray solution is highly acidic, the phosphate backbone tends to be 
negatively charged in the gas phase.  Thus detection of nucleic acids is more efficient in 
negative ion mode.  However, nucleobases are basic and can be protonated both in 
solution and in the gas phase.  ECD of oligonucleotides has been demonstrated to yield 
primarily a/z and d/w-type ions, as well as c/x-type ions.52, 173  Due to the sequence 
symmetry of the investigated oligonucleotides, a- and z-ions have the same mass and thus 
cannot be differentiated in the mass spectra.  Similar ambiguity is also present in b/y, c/x 
and d/w-type ions. 
Recently, negative ion electron capture dissociation (niECD) has been 
demonstrated to fragment peptides in the gas phase in a manner analogous to ECD in 
positive ion mode,121 however, niECD operates in negative ion mode.  In niECD, peptide 
anions capture 3.5-6.5 eV electrons to form charge-increased radicals that fragment to 
c/z-type ions. 
1.5.6 Electron Detachment Dissociation (EDD) 
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ECD requires multiply charged cations as precursor ions.  EDD is a negative ion 
mode ion-electron reaction in which multiply charged anions are irradiated with electrons 
of energy higher than 10 eV.  This higher electron energy (compared to 3.5-6.5 eV in 
niECD) ejects an electron from the precursor anions to form an electron-deficient odd-
electron intermediate different from the electron-rich intermediate formed in niECD.  
This radical intermediate further dissociates, as shown in Scheme 1.7.  EDD has been 
implemented in FT-ICR and quadrupole ion trap instruments.174  For peptides, the major 
product ions in EDD are a• and x-type ions, as well as abundant CO2 loss.117  EDD has 
shown the ability to retain PTMs such as phosphorylation175 and sulfonation.117  
 
Scheme 1.7.  Fragmentation route in EDD. 
EDD has also been demonstrated to efficiently dissociate oligonucleotides.53, 176  
For oligodeoxyribonucleotides, EDD primarily provides a, c, d and w-type ions whereas, 
for oligoribonucleotides, primarily d and w-type ions are observed.  As a radical-driven 
process, EDD provides complementary sequence information compared to slow-heating 
techniques such as CAD and IRMPD.  In contrast to CAD, nucleobase loss is not favored 
in EDD, as observed after carefully minimizing collisional activation during the 
experiment.177  
1.6 Dissertation Overview 
This dissertation research is on mass spectrometric method development for 
detection and characterization of biomacromolecules, with a particular focus on acidic 
peptides, proteins, and nucleic acids.  This chapter provided a broad overview of basic 
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concepts related to ESI-FT-ICR-MS and its applications.  The following chapters are 
grouped to answer three general questions from methodology development in mass 
spectrometry.  
Chapters 2-5 demonstrate how to extend existing mass spectrometric techniques 
to molecules not previously studied by these techniques.  In Chapter 2, various MS/MS 
techniques are evaluated for sequencing peptide nucleic acids (PNAs).  In Chapter 3, 
various MS/MS techniques are applied to large RNAs and RNA-ligand complexes for 
obtaining sequence information and ligand binding sites.  In Chapter 4, negative ion 
mode MS/MS techniques are applied to acidic proteins.  Sequence information obtained 
from negative ion mode is compared to positive ion mode analysis.  In Chapter 5, a 
recently developed MS/MS technique is evaluated for sequencing oligonucleotides.  
Chapter 6 demonstrates how to improve new mass spectrometric techniques.  In this 
Chapter, niECD, an MS/MS technique recently developed in our laboratory, is modified 
to improve fragmentation efficiency and practical utility. 
Appendix A demonstrates how to apply mass spectrometric techniques to solve 
practical problems from biology through collaborative efforts.  Through collaboration 
with Dr. Xiaoxia (Nina) Lin and Dr. Marjan Varedi, workflows for bottom-up and top-
down approaches are established to understand the regulatory activity of the yeast protein 
Sic1.   
The Chapters in this dissertation are prepared in the format of journal articles that 
will be submitted for publication. 
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Chapter 2 
Gas-phase Ion Activation Techniques for Characterization of Peptide 
Nucleic Acids (PNAs) 
 
2.1 Introduction 
Peptide nucleic acids (PNAs) are nucleic acid analogs in which the backbone is 
replaced by a synthetic peptide-like backbone, as shown in Figure 2.1.  They were 
designed to bind nucleic acids in a sequence-specific manner, through Watson-Crick 
bonding rules.1-3  In PNAs, 2-aminoethyl-glycine units replace the labile phosphate-sugar 
backbone units in regular DNA/RNA.  The length and flexibility of the PNA backbone 
offer the ability of PNAs to bind single-strand and duplex DNA/RNA.4, 5  The uncharged 
nature of the PNA backbone offers higher stability than non-PNA complexes, due to 
reduction in electrostatic repulsion.  The PNA backbone is resistant to proteases and 
nucleases because it is neither peptide- nor nucleic acid-like.  The design of the PNA 
backbone provides higher thermal stability and chemical resistance of PNA containing 
complexes compared with regular DNA or RNA complexes,6 and also results in unique 
ionic properties. 
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Figure 2.1. Structure of the PNA CAGCAG.  
PNAs have been investigated and applied in many areas.  First they were 
developed as drug candidates.  Through inhibition of DNA replication,7 mRNA 
transcription,8, 9 and protein translation10, 11 PNAs have shown promise in antigene and 
antisense applications.12  However, delivery of PNAs through the cell membrane is one 
major challenge preventing use of PNAs as drugs.13, 14  Second PNAs have been adapted 
in biotechnologies such as biosensors for detection of single nucleotide polymorphisms 
(SNP)15, 16 and mutations,17 as well as for enhancing PCR efficiency18, 19 and telomere 
analysis.20 
Sequencing of PNA can be performed by tandem mass spectrometric techniques 
such as collision activated dissociation (CAD), infrared multiphoton dissociation 
(IRMPD),21, 22 and electron capture dissociation (ECD).23  In positive ion mode, the 
nucleobases and terminal primary amines are most likely to be protonated.  Water loss, 
methylene carbonyl linker loss, nucleobase loss, and backbone cleavages are observed in 
CAD24-28 and similar fragmentation patterns are seen in IRMPD.27, 28  In ECD, water loss 
is limited compared to CAD and IRMPD.  However, the overall fragmentation efficiency 
is lower in ECD.26-28  Despite the lack of acidity of the PNA backbone PNA-DNA or 
PNA-RNA complexes show improved ionization efficiency in negative ion mode 
compared to positive ion mode, due to the acidic DNA or RNA backbone.  PNA itself 
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also ionizes well in negative ion mode.25  Backbone cleavages and neutral loss fragments 
are observed in negative ion CAD with backbone cleavages being more dominant than in 
positive ion mode.25  Even less water loss was observed in CAD of PNAs acetylated at 
the N-terminus and similar patterns were observed in IRMPD.28 
In this Chapter, non-acetylated PNA fragmentation in both positive and negative 
ion mode by CAD, IRMPD, ECD (positive ion mode only) and electron detachment 
dissociation (EDD, negative ion mode only) is examined.  Also, double resonance and 
acetylation are employed to investigate the mechanism of water loss. 
2.2 Experimental Section 
2.2.1 Sample Preparation 
PNAs including CAGCAG and ATGTCAGTCA were purchased from Bio-
synthesis Inc. (Lewisville, TX).  All reagents were used without further purification.  In 
acetylation reactions, 2 μL of PNA at 100 μM was mixed with 100 mL of 1:3 v/v acetic 
anhydride (Sigma-Aldrich)/methanol (Fisher).  The reaction mixture was kept at room 
temperature for 24 hours and then evaporated to dryness.  PNAs and acetylated PNAs 
were diluted into 1:1 v/v isopropanol (Fisher, Fair Lawn, NJ) /water (Fisher) with 10 mM 
ammonium acetate (Fisher) to 5 µM for negative ion mode, and into 1:1 v/v methanol 
(Fisher)/water with 2% v/v acetic acid (Sigma-Aldrich) to 1 µM for positive ion mode 
analysis. 
2.2.2 Mass Spectrometry 
All mass spectra were acquired on a Bruker Apex-Q 7T ESI-FT-ICR mass 
spectrometer (Bruker Daltonics, Billerica, MA).  Samples were infused via an Apollo II 
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electrospray source (Bruker Daltonics, Billerica, MA) at 50 μL/h.  Precursor ions for 
MS/MS were selected by the quadruple and accumulated externally in the collision cell 
(hexapole).  CAD experiments were conducted by acceleration of precursor ions into the 
collision cell filled with argon at 6×10-6 mBar.  IRMPD experiments were conducted by 
irradiating precursor ions in the ICR cell by a laser beam from a CO2 laser at 12.5 W for 
20-100 ms.  ECD and EDD experiments were conducted by irradiating precursor ions in 
the ICR cell by an electron beam from an indirectly heated cathode.  For ECD 
experiments, the cathode bias voltage was set to - 1 V and a lens located between the 
cathode and the ICR cell was set to 1 V.  For EDD experiments, the cathode bias voltage 
was between - 18 and - 25 V and the lens voltage was kept 1 V lower than the cathode 
bias voltage, i. e. - 19 and - 26 V.  For double resonance IRMPD experiments, a 
waveform containing the frequency corresponding to the m/z ratio of interest was applied 
to the excitation electrodes while the laser beam was irradiating the precursor ions.  For 
MS3 experiments, after the first MS/MS event, product ions of interest were isolated in 
the ICR cell by a correlated harmonic excitation field (CHEF)29 waveform containing all 
frequencies corresponding to ions to be ejected, then subjected to IRMPD.  Mass spectra 
were averaged over 64 to 256 scans.  Data files were processed by MIDAS30 software. 
2.3 Results and Discussion 
2.3.1 CAD, IRMPD and ECD of the PNAs CAGCAG and ATGTCAGTCA in 
Positive Ion Mode 
The structure of the PNA 5’-CAGCAG-3’ is shown in Figure 2.1.  Different 
nomenclatures for PNA fragmentation were proposed by Takao et al.,31 Muddiman et 
al.,24 and Zubarev et al.26  In this Chapter the nomenclature from Zubarev et al., which is 
based on commonly accepted peptide notation is adopted.32  In the Zubarev nomenclature 
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a, b, c, d, x, y, z and w-type ions correspond to b, c, d, e, v, w, x, and y-type ions in the 
Muddiman nomenclature.  The Zubarev nomenclature is show in Figure 2.2. 
 
Figure 2.2.  Product ion nomenclature used in this Chapter. Adapted from Zubarev et 
al.26 
CAD, IRMPD and ECD were performed on triply protonated precursor cations, 
[M + 3H]3+.  Mass spectra are shown in Figure 2.3.  Backbone cleavages are mapped 
onto the PNA sequence, as shown in Figure 2.4.  Other assigned peaks in the CAD 
spectrum, not labeled in Figure 2.3, are listed in Table 2.1. 
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Figure 2.3.  CAD (16 V collision cell voltage), IRMPD (7.5 W, 80 ms), and ECD (- 1 V, 
7 ms) MS/MS spectra of the PNA CAGCAG.  Only b, c, y and z-type ions without 
neutral loss are labeled. 
 
Figure 2.4.  Backbone cleavages from CAD, IRMPD, and ECD of the PNA CAGCAG in 
positive ion mode.  Product ion labels include combined backbone/neutral loss cleavages.  
For example, “b” labels include b, (b - H2O), and (b - base) ions.   
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Observed m/z Calculated m/z Assignment 
Abundance 
(%) 
Error 
(ppm)
234.1002 234.0991 (b1 - H2O)+ 0.53 4.60
291.1331 291.1312 (y1 - H2O)+ 2.38 6.38
433.2067 433.2054 (y2 - G)+ 3.90 2.88
433.2067 433.2054 (c2 - C)+ 3.90 2.88
471.1855 471.1847 (w2 - A - H2O)+ 2.60 1.79
509.2125 509.2116 (b2 - H2O)+ 5.26 1.80
554.7301 554.7307 (y4 - H2O) 2+ 2.56 -0.93
566.2443 566.2443 (y2 - H2O)+ 31.27 0.06
604.7623 604.7571 (c5 - H2O - A)2+ 4.70 8.55
674.7901 674.7864 [M - A - G - H2O]2+ 4.63 5.47
684.2792 684.2778 (z5 - H2O)2+ 0.38 2.03
686.7954 686.7920 [M - H2O - C - G]2+ 16.59 4.90
692.2848 692.2875 (y5 - H2O)2+ 34.74 -3.86
733.3094 733.3084 [M - G -2H2O]2+ 9.20 1.35
742.3141 742.3134 [M - G - H2O]2+ 100.00 0.90
746.2928 746.2977 (w3 - C - H2O)+ 5.34 -6.63
751.3198 751.3190 [M - G]2+ 48.66 1.10
762.3107 762.3167 [M - C -H2O]2+ 5.25 -7.94
800.3142 800.3195 (b3 - H2O)+ 6.25 -6.66
817.3428 817.3461 (y3 - H2O)+ 2.54 -3.96
957.4049 957.4046 (y4 - G - H2O)+ 8.97 0.28
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957.4049 957.4046 (c4 - C - H2O)+ 8.97 0.28
1193.4903 1193.4955 (b5 - G)+ 0.79 -4.37
1232.5105 1232.5177 (c5 - C - H2O)+ 17.73 -5.82
1232.5105 1232.5177 (y5 - G - H2O)+ 17.73 -5.82
1250.5179 1250.5283 (c5 - C)+ 5.22 -8.28
1250.5179 1250.5283 (y5 - C)+ 5.22 -8.28
1350.5807 1350.5807 [M - 2G]+ 10.08 0.00
Table 2.1.  List of assigned peaks in the positive ion mode CAD spectrum of the PNA 
CAGCAG.  These assignments are not included in Figure 2.3. 
 
For the PNA CAGCAG, CAD and IRMPD provide complete sequence coverage.  
However, abundant neutral losses are observed, that complicate spectrum interpretation.  
Neutral losses include water loss and nucleobase loss.  Previous experimental and 
theoretical studies have proposed PNA fragmentation mechanisms.25  As for water loss, 
two mechanisms corresponding to N-terminal25 and C-terminal33 water losses have been 
proposed.  Proposed C-terminal water loss is charge independent whereas the proposed 
N-terminal water loss is dependent on the protonation sites.  An MS3 experiment was 
performed in which [M - H2O]3+ generated from CAD in the external collision cell was 
fragmented by SORI-CAD in the ICR cell.  The corresponding spectrum is shown in 
Figure 2.5. 
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Figure 2.5. MS3 (CAD of M3+  followed by SORI-CAD of [M - H2O]3+) of the PNA 
CAGCAG. 
In the MS3 spectrum, b1 and (b1 - H2O), y1 and (y1 - H2O), as well as y5 and (y5 - 
H2O) ions are observed, indicating that water loss occurs from both the N- and C-termini.  
This result is consistent with Ballistreri et al.33 and Flora et al.25  In order to further 
explore the mechanism of water loss, double resonance experiments were performed in 
which [M - H2O]3+ was continuously ejected from the ICR cell while IRMPD was being 
performed. The results of the experiment are shown in Figure 2.6.  
  
52 
 
 
 
Figure 2.6.  IRMPD of the triply protonated PNA CAGCAG with and without 
simultaneous double resonance (DR) ejection of [M - H2O]3+.  (a) Zoomed spectrum 
without DR, showing [M - H2O]3+ and M3+.  (b) Zoomed spectrum with DR.  (c) Zoomed 
spectrum without DR, showing [y2 - H2O]+.  (d) Zoomed spectrum with DR. 
 
Figure 2.7.  Abundance changes of precursor and y-type product ions with and without 
DR in IRMPD of the PNA CAGCAG. 
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Figure 2.7 illustrates the abundance of precursor ions and y-type fragment ions in 
IRMPD experiments with and without DR.  Simultaneous ejection of [M - H2O]3+ 
dramatically affected the formation of (y1 - H2O), (y2 - H2O), and (y4 - H2O) as well as 
decreased the formation of (y5 - H2O).  This result indicates that water loss either 
primarily occurs from the C-terminus, or that one of the y-ion formation pathways 
involves water loss.  
In the ECD spectrum of CAGCAG, only c1, c2, and z3 fragments of low 
abundance are observed.  Water loss, base lose, and unassignable peaks constitute the 
major product ions.  This result appears consistent with previous observations by Olsen et 
al.26 
CAD, IRMPD and ECD of the quadruply protonated PNA ATGTCAGTCA were 
also performed.  Backbone fragments are shown in Figure 2.8. 
  
Figure 2.8. Backbone cleavages from CAD, IRMPD and ECD o the PNA 
ATGTCAGTCA in positive ion mode.  Product ion labels include combined 
backbone/neutral loss cleavages.  For example, “b” labels include b, (b - H2O), and (b - 
base) ions. 
From CAD and IRMPD spectra, full sequence coverage was obtained.  However, 
abundant water loss, base loss, and unassignable peaks dominate the spectra.  In order to 
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reduce water loss, acetylation of the N-terminus was performed.  IRMPD spectra of the 
10-mer PNA ATGTCAGTCA and its acetylated variant are shown in Figure 2.9. 
 
Figure 2.9. IRMPD spectra of the non-acetylated 10-mer PNA ATGTCAGTCA (upper 
panel) and its acetylated variant (bottom panel). 
From Figure 2.9 it can be seen that, before acetylation, b1 through b8 ions are 
observed with water loss.  By contrast, after acetylation, b1, b2, b3, b5, b7, and b8 ions are 
observed without water loss.  However, all y ions are observed with water loss following 
acetylation.  This result indicates that acetylation blocks one of the water loss pathways – 
the one corresponding to N-terminal water loss.  The IRMPD spectrum of the acetylated 
10-mer PNA is easier to interpret than the one for the non-acetylated form.  This result is 
consistent with previous results obtained in negative ion mode.34 
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ECD of the PNA ATGTCAGTCA provided only one backbone cleavage.  Peaks 
from neutral loss and unassignable peaks dominate the spectrum.  Similar fragmentation 
patterns were previously observed for 12-mer and 13-mer PNAs.28 
2.3.2 CAD, IRMPD and EDD of the PNAs CAGCAG and ATGTCAGTCA in 
Negative Ion Mode 
CAD, IRMPD and EDD were performed on the triply deprotonated anionic PNA 
CAGCAG, [M - 3H]3-, as shown in Figure 2.10.  Backbone cleavages were mapped to the 
sequence as shown in Figure 2.11.  Other assigned peaks in the CAD spectrum, not 
labeled in Figure 2.10, are listed in Table 2.2. 
 
Figure 2.10.  Negative ion mode CAD (19 V collision cell voltage), IRMPD (7.5 W, 180 
ms), and EDD (- 18 V, 2 s) MS/MS spectra of the PNA CAGCAG.  Only a, b, x, and y-
type ions without neutral loss are labeled. 
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Figure 2.11.  Backbone cleavages from CAD, IRMPD and EDD of the PNA CAGCAG 
in negative ion mode.  Product ion labels include combined backbone/neutral loss 
cleavages.  For example, “b” labels include b, (b - H2O), and (b - base) ions. 
Observed 
m/z 
Calculated  
m/z 
Species 
Abundance 
(%) 
Error 
(ppm) 
482.2062 482.2018 (a2 - NH3)- 5.82  9.10 
627.7596 627.7549 (e5 - C - H2O)2- 1.49  7.37 
649.2636 649.2578 (a5 - NH3)2- 4.54  8.92 
690.2767 690.2718 (y5 - H2O)2- 1.89  7.13 
706.7993 706.7951 [M - 2C - H2O]2- 3.27  5.87 
715.8053 715.8004 [M - 2C]2- 9.46  6.80 
740.302 740.298 [M - H2O - G]2- 0.97  5.40 
749.3121 749.3041 [M - G]2- 1.20  10.65 
790.3391 790.3357 a3- 2.35  4.28 
794.3249 794.3198 [M - CONH - H2O]2- 36.39  6.42 
803.3298 803.3251 [M - CONH]2- 100.45  5.92 
815.8263 815.8235 [M - H2O]2- 30.25  3.34 
816.3228 816.3155 [M - NH3]2- 38.24  8.88 
981.408 981.4057 (e4 - C - H2O)- 1.18  2.26 
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1024.414 1024.41 (a4 - NH3)- 3.22  3.27 
1081.443 1081.432 (d4 - NH3)- 3.27  9.83 
1106.43 1106.438 (y4 - H2O)- 2.79  -7.27 
1150.429 1150.429 x4- 1.26  -0.26 
Table 2.2. List of assigned peaks in negative ion mode CAD of the PNA CAGCAG.  
These peaks are not included in Figure 2.10. 
 
From CAD and IRMPD spectra, full sequence coverage was obtained, 
respectively.  Fragmentation patterns are similar between CAD and IRMPD.  Neutral loss 
including water loss, ammonia loss, base loss, and -CONH loss are observed for both the 
precursor ion and fragment ions.  However, neutral loss peaks are more abundant for the 
precursor ion compared to the fragment ions.  In terms of b/y ion series in the CAD 
spectrum, b2, b4, b5, and y1 - y3 ions are observed only in the form without water loss.  By 
contrast, y4 and y5 are observed both with and without water loss.  Compared to CAD in 
positive mode, CAD in negative mode provided more intact b/y ions without extensive 
neutral losses, thus generating a spectrum less complicated to interpret. 
From EDD, four out of 10 possible backbone cleavages are observed from a/x ion 
series.  However, peaks associated with neutral loss and unassignable peaks are still 
dominant. 
CAD, IRMPD and EDD were also performed on the quadruply deprotonated PNA 
ATGTCAGTCA.  Backbone fragments are shown in Figure 2.12. 
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Figure 2.12.  Backbone cleavages from CAD, IRMPD, and EDD of the PNA 
ATGTCAGTCA in negative ion mode.  Product ion labels include combined 
backbone/neutral loss cleavages.  For example, “b” labels include b, (b - H2O), and (b - 
base) ions. 
From CAD and IRMPD spectra, full sequence coverage was obtained, 
respectively.  Fragmentation patterns are similar between CAD and IRMPD.  Similar to 
CAD and IRMPD of CAGCAG, neutral loss, including water loss, ammonia loss, base 
loss and -CONH loss is observed for both the precursor ion and fragment ions.  In CAD, 
b2, b3, b4, b7, b8, y5, y6, and y9 ions are observed only in intact form without water loss 
whereas b5, b6, b9, and y3 ions are observed both with and without water loss.  y4 and y7 
ions are observed only in association with water loss.  Intact b/y ions were more abundant 
compared to their water loss variants.  This fragmentation pattern is consistent with CAD 
of the PNA CAGCAG in negative mode. In EDD, no backbone cleavages are observed 
and neutral loss and unassignable peaks are dominant. 
2.4 Conclusions 
In this Chapter, the MS/MS fragmentation patterns of a 6-mer and a 10-mer PNA 
in positive and negative ion mode were examined. The MS/MS techniques studied 
include CAD, IRMPD, ECD, and EDD.  
For CAD in positive ion mode, full sequence coverage was obtained.  However, 
neutral loss, including water and nucleobase loss from both precursor and product ions, 
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dominated the spectra.  An MS3 experiment revealed that water loss occurs from both the 
N- and C-terminus.  A double resonance experiment revealed that water loss occurs from 
the C-terminus, or that one of the y-ion formation pathways involves water loss.  IRMPD 
provided similar fragmentation patterns as CAD.  Acetylation on the N-terminus of the 
10-mer PNA blocked the water loss pathway involving the N-terminus.  The IRMPD 
spectrum of the acetylated 10-mer PNA was easier to interpret compared to the spectrum 
of the non-acetylated variant due to reduced water loss from the fragments.  ECD of 6-
mer and 10-mer PNAs provided less backbone cleavages than CAD and IRMPD and also 
yielded abundant neutral loss peaks.  
For CAD in negative ion mode, full sequence coverage was also obtained.  
Neutral loss including water loss, ammonia loss, nucleobase loss, and -CONH loss was 
observed for precursor and fragment ions. However, compared to positive ion mode, ions 
with neutral loss were of less abundance.  Thus CAD spectra in negative mode were 
easier to interpret compared with positive ion mode.  This result is consistent with 
previously reported results.28, 34  EDD of the 6-mer and 10-mer PNAs provided less 
backbone cleavages than CAD and IRMPD and also abundant neutral loss peaks. 
Overall, operating CAD and IRMPD in the negative ion mode, as well as 
acetylating the N-terminus, reduce the abundance of neutral loss peaks and simplify 
spectrum interpretation. 
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Chapter 3 
Top-down MS/MS of Ribonucleic Acids and Their Complexes 
 
3.1 Introduction 
Characterization of biomolecules by mass spectrometry (MS) and tandem mass 
spectrometry (MS/MS) has been gaining popularity since the emergence of electrospray 
ionization (ESI),1 a “soft” ionization technique able to introduce labile molecules into the 
gas phase.  The “top-down” approach of mass spectrometry, i.e., analysis of large 
biomacromolecules in their intact form, has been primarily applied for characterization of 
proteins. 2, 3  However, top-down analysis has also been successfully applied to nucleic 
acids.  For example, intact masses of transfer ribonucleic acids (tRNAs)4 and polymerase 
chain reaction (PCR) products5, 6 have been obtained from mass spectrometry.  In top-
down MS/MS, intact nucleic acid ions are dissociated in the gas phase.  Based on the 
fragments observed, sequence or structural information can be obtained.  Top-down 
MS/MS has been applied to tRNAs7 small interfering RNAs (siRNAs),8 RNA-protein 
complexes,9, 10 RNA-ligand complexes,11-14 and HIV-1 SL1 RNA15. 
”Slow heating” MS/MS techniques, including collision activated dissociation 
(CAD)16, 17 and infrared multiphoton dissociation (IRMPD)18, 19 are the most common for 
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analysis of RNAs.  In CAD, precursor ions are heated by gaseous inelastic collisions 
between accelerated ions and neutral molecules such as argon.  During the activation 
process, each inelastic collision deposits a small amount of internal energy to the 
precursor ion.  The energy from each collision is not sufficient to dissociate a molecular 
bond.  However, energy is accumulated from multiple collisions to overcome the 
dissociation threshold.  For RNAs, CAD provides primarily c and y-type backbone 
product ions, as well as (a - B)/w-type ions and product ions from neutral loss of small 
molecules. 8, 20-22  CAD has been applied to both small and large (up to 108 nt) DNAs.23, 
24  Recently it was applied to dissociate RNAs with sizes up to 61 nt.7, 22, 25  IRMPD is 
another type of slow-heating technique, that activates ions by depositing energy from IR 
photon absorption.  IRMPD typically provides comparable backbone fragmentation 
patterns to CAD.26  However, oligonucleotides are more labile in IRMPD compared to 
proteins and peptides due to strong absorption of 10.6 mm photons from resonance with 
the P-O stretching frequency of the oligonucleotide phosphodiester backbone.18, 27  When 
implemented in ion trap instruments, IRMPD provides advantages compared with CAD 
because ion loss due to collisional scattering is minimized, and also no rf voltage is 
needed for precursor ion excitation, thus eliminating the instability (i.e., 1/3 rule) for low 
m/z product ions.28  
Electron capture dissociation (ECD)29-31 is a reaction between multiply positively 
charged precursor ions and low energy electrons.  During this reaction, a cation captures 
one electron to form a meta-stable radical intermediate that further dissociates into 
fragments.  ECD has been demonstrated to dissociate oligonucleotides.32, 33  However, 
due to the acidity of the phosphate backbone, nucleic acids are detected more sensitively 
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in negative ion mode compared with positive ion mode.  Thus ECD has been limited to 
the analysis of short oligonucleotides rather than polynucleotides.  
Electron detachment dissociation (EDD)34 is a reaction between multiply 
negatively charged precursor ions and electrons of relatively high energy.  During this 
reaction, an anion is bombarded with electrons to lose electrons and forms a meta-stable 
radical intermediate that further dissociates into fragments.  EDD has been demonstrated 
to dissociate oligonucleotides35-37 and, more recently, large RNAs (up to 61nt)25.  EDD 
was also attempted on several DNA complexes, however, only electron detachment was 
observed.38  Major products ions from EDD of nucleic acids are d- and w-type ions.  For 
DNAs it has been shown that base loss is a secondary fragmentation pathway while 
backbone cleavage is primary.39, 40  In other work, it was observed that EDD is able to 
preserve non-covalent bonding in the gas phase.39, 41 
Here an effort is made to characterize a 27-mer RNA and its small molecule 
complexes by MS/MS techniques including EDD and negative ion CAD, as well as ion 
mobility mass spectrometry (IM-MS).  The 27-mer RNA R1 is representative of the A-
site structure of 16S rRNA in prokaryotic cells and is known to form complexes with 
aminoglycoside antibiotics.11, 12   
3.2 Experimental Section 
3.2.1 Sample Preparation 
The 27-mer RNA R1 (5’-GGCGUCACACCUUCGGGUGAAGUCGCC-3’) was 
purchased from Integrated DNA Technologies, Inc. (Coralville, IA) and desalted by 
ethanol precipitation (protocol modified from Limbach et al.42). 1 nmole of RNA was 
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mixed with 20 μL of 7.5 M NH4OAc and 80 μL of cold ethanol.  This mixture was 
vortexed, stored at - 80 °C for 3 hours, and centrifuged for 30 minutes.  The supernatant 
was discarded.  200 μL of 90% cold ethanol was added to the precipitate and stored at - 
80 °C for 2 h.  The resulting mixture was then centrifuged at 12,000 g for 30 minutes and 
the supernatant was discarded.  The precipitate was dissolved in electrospray solution for 
electrospray ionization.  Aminoglycosidic antibiotics, including paromomycin (PM), 
ribostamycin (RM), (Be)kanamycin (BK), and apramycin (AP) were purchased from 
Sigma-Aldrich (St. Louis, MO). 
3.2.2 Mass Spectrometry and Ion Mobility-Mass Spectrometry 
Mass spectra were obtained with a 7-T quadrupole-FT-ICR mass spectrometer 
(Apex-Q, Bruker Daltonics, Billerica, MA).  The desalted RNA was dissolved in 1% 
triethylamine (TEA) and 10%, 30%, or 50% methanol in water (v/v).  Solutions were 
infused via an Apollo II electrospray ion source at a flow rate of 70 μL/hour.  Ions with 
mass to charge ratios of interest were selected by an external quadrupole, accumulated in 
a hexapole, and transported to the ICR cell for dissociation and detection.  Beam-type 
CAD experiments were performed by accelerating selected precursor ions into the 
hexapole filled with argon at 6 x 10-6 mbar.  EDD experiments were performed in the 
ICR cell by irradiating precursor ions with an electron beam generated by an indirectly 
heated hollow dispenser cathode for 1-2 s.  The cathode bias voltage was adjusted 
between - 20 and - 30 V.  A lens located between the cathode and the ICR cell was set to 
around 1 V higher than the cathode bias voltage, i. e. between - 19 V and - 29 V.  For 
activated ion (AI) EDD experiments, precursors ions in the ICR cell were irradiated with 
an infrared laser beam from a 25-W, 10.6-μm, CO2 laser (Synrad, Mukilteo, WA) at 5% 
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power for 20-50 ms, then irradiated with the electron beam for 1-2 s as described above.  
Electrons were extracted from an indirectly heated ring cathode heated with a current of 
1.8 A.  Mass spectra were processed by DataAnalysis software (Bruker Daltonics) and 
manually interpreted.  Ion mobility mass spectra were obtained with a Q-IM-TOF 
instrument (Synapt G2, Waters, Milford, MA, USA).  Solutions were infused via a 
nanoESI source with in-house generated fused silica capillary tips.  Data sets were 
processed by MassLynx software (Waters). 
3.3 Results and Discussion 
3.3.1 Effects of Organic Solvent in Electrospray Solution on 27-mer RNA Gas-
phase Structure 
The 27-mer RNA R1 5’-GGCGUCACACCUUCGGGUGAAGUCGCC-3’ has 
been proposed to form a hairpin structure, as shown in Figure 3.1.43  It has been revealed 
by CAD of an RNA R1 analog that A1408, A1492, and A1493 are binding sites for 
aminoglycoside antibiotic drugs.11, 43  The R1 analog consisted of 2’-O-
methylribonucleotides except for the potential ligand binding sites, which consisted of 
deoxynucleotides with the same nucleobases as RNA R1.  X-ray crystallography and 
cryo-electron microscopy have been employed to determine the 3-D structure of 
aminoglycoside-bound 16S rRNA, as shown in Figure 3.2.44-46  One aminoglycoside 
ligand binds into the groove containing A1408, A1492, and A1493 of 16S rRNA. 44-46 
67 
 
 
Figure 3.1. Sequence and secondary structure of the 27-mer RNA R1.  The numbering is 
relative to 16S ribosomal RNA.  Adapted from Griffey et al.43 
 
Figure 3.2.  3D structure of aminoglycoside-bound sites on tRNA, mRNA, and 70S 
prokaryotic rRNA.  70S rRNA incorporates 16S rRNA as a subunit.  Figure adapted from 
[44]. 
R1 was electrosprayed from a solution containing 1% triethylamine and 50% 
methanol in water.  The electrospray solution was adapted from Taucher et al.,25 who 
demonstrated that RNAs up to 61 nt could be dissociated by CAD and EDD.  We 
observed charge states ranging from 5- to 13-, as shown in Figure 3.3.  The average 
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charge density is ~0.3 per nucleotide (nt), which is lower than ~0.4 for a 34-mer 
riboswitch aptamer RNA as reported previously.22  The latter 34-mer RNA has been 
proposed to contain less base-pairing than the present 27-mer RNA, and thus should have 
a less ordered structure.47  
  
Figure 3.3.  Negative ion ESI spectrum of the 27-mer RNA R1.  
There are two charge state distributions, or two “envelopes”, in the ESI spectrum 
of RNA R1, which is an indication that more than one gas-phase conformation may exist 
simultaneously.  An ion mobility mass spectrum of RNA R1 shows two distinct groups of 
conformations (Figure 3.4). 
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Figure 3.4.  IM-MS of RNA R1 dissolved in 1% triethylamine and 50% (v/v) methanol 
in water.  
Collision cross sections (CCSs), or sizes of RNA R1 anions with higher charge 
states (8- to 13-) are larger than lower charge states (6- to 5-), demonstrating that anions 
with more charges are more unfolded and anions with less charges are more folded.  The 
CCS of the 7- charge state lies between the two groups, indicating that 7- anions are 
partially unfolded.  Within the group of higher charge states, CCSs at higher charge states 
are slightly larger than for lower charge states.  When the RNA R1 was electrosprayed 
from 25 mM ammonium acetate in 50% (v/v) methanol in water, similar overall CCSs 
were observed.  The percentage of organic solvent in the electrospray solution may 
impact the gas phase structure.  The differences of observed CCSs of RNA R1 anions 
electrosprayed from 10%, 30%, and 50% methanol in water are summarized in Figure 3.5.  
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Figure 3.5.  CCS comparison of RNA R1 electrosprayed from solutions with different 
methanol content. 
CCSs of RNA R1 at the 7- and 8- charge states electrosprayed from 50% 
methanol are larger than from 10% methanol while, at other charge states, CCSs are 
similar.  This result indicates that 50% methanol content aids the unfolding of RNA R1 at 
the 7- and 8- charge states while it does not affect gas-phase structures of RNA R1 at 
other charge states.  Based on these data, it can be proposed that RNA gas-phase structure 
is strongly dependent on charge state.  Also, lower methanol content does not aid the 
preservation of RNA folding at certain charge states.  RNA R1 electrosprayed from 30% 
methanol content share similar sizes as from 10% methanol content for all observed 
charge states.  Up to 10% organic solvent was used in previous RNA-ligand binding 
specificity studies.11, 43 
3.3.2 Dependence of EDD and CAD Fragmentation Efficiency on Precursor Ion 
Charge State 
EDD and CAD were performed on RNA R1 at charge states from 5- to 8-, 
electrosprayed from 50% methanol (v/v) in water with 1% trimethylamine.  Infrared laser 
irradiation was applied prior to EDD to activate the precursor ions.  Absence of IR 
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activation resulted in limited EDD backbone cleavages.  An activated ion (AI)-EDD 
spectrum of [M - 8H]8- is shown in Figure 3.6. 
 
Figure 3.6.  AI-EDD spectrum of the RNA R1 at a charge state of 8-.  IR activation prior 
to EDD was performed by irradiating the [M - 8H]8- ion with a 10.6 µm laser beam at 
0.125 W for 150 ms.  EDD was performed by irradiating precursor ions with electrons for 
0.4 s.  Electrons were extracted at a voltage of - 25 V and filtered by a lens voltage set at 
-24 V.  Upper panel: d and w-type ions are labeled as circles.  
Backbone d- and w-type ions observed in AI-EDD of different charge states are 
mapped to the RNA R1 sequence, as shown in Figure 3.7. 
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Figure 3.7.  Backbone cleavages observed in AI-EDD of the RNA R1 at charge states of 
5- to 8-. 
AI-EDD of the RNA R1 at the 10- charge state provided 46 out of 52 possible 
backbone cleavages.  However, AI-EDD of the 5- charge state only provided three 
backbone cleavages in the form of d/w-type ions.  Figure 3.8 illustrates the comparison of 
the numbers of d/w-type ions observed in AI-EDD spectra from different precursor 
charge states, as well as the numbers of c/y-type ions observed in CAD spectra.  
 
Figure 3.8.  Charge dependence of EDD and CAD efficiency.  Charge density (charge/nt) 
is noted under each number of negative charges. 
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As the charge state of the precursor ions increased from 5- to 8-, AI-EDD 
provided more backbone cleavages in the form of d/w-type ions.  The number of d/w-type 
ions does not significantly change between the 8-, 9- and 10- precursor ion charge states.  
A dependence of fragmentation efficiency on precursor charge state has been observed in 
other ion-electron reactions such as ECD of peptides48 and ETD of peptides.49  The effect 
of precursor charge state on the number of observed backbone fragments may be due to 
two reasons: One reason is the fact that, in FT-ICR detection, signal from image current 
is proportional to the number of charges.  Product ions from precursor ions with more 
charges may carry more charges and be detected with higher sensitivity.  The other 
reason is the correlation between gas-phase size and number of charges.  Coulomb 
repulsion between charges on the RNA may facilitate unfolding of the molecule in the 
gas phase, similar to proteins.50  A larger cross-section increases the chance of overlap 
between precursor anions and the electron cloud during the EDD event.  Also a more 
unfolded gas-phase structure contains less non-covalent bonding, which may hinder 
dissociation of complementary fragments after backbone cleavage occurs.  Figure 3.4 
shows that RNA anions are more expanded as the charge state increased from 6- to 8-.  
The size expansion from 8- (0.30 charges/nt) to higher charge states is not as significant 
as from 6- to 8-.  The trend of size expansion with charge increase is consistent with the 
trend of increased observation of d/w-type ions.  Size expansion in the gas phase along 
with charge increase was also observed for three DNAs (28-mer, 40-mer, and 55-mer).51  
In the latter study the gas-phase size expanded dramatically with the charge increase 
when the charge density was lower than 0.30 charges/nt.  By contrast the size expansion 
was not as significant when the charge density was higher than 0.30 charges/nt.  
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Interestingly, in this study of RNA R1, 0.3 charges/nt is also the turning point in the trend 
line of size expansion and the trend line of the number of observed d/w-type ions.  
Taucher et al. also compared EDD fragmentation efficiencies of 22-mer RNA anions at 
two different charge states.25  Both charge states had higher charge densities than 0.30 
charges/nt (0.45 and 0.59, respectively) and their fragmentation efficiencies were similar.  
Our EDD and IM-MS data, combined with previously published results from EDD and 
CCS measurements, support the existence of a correlation between EDD fragmentation 
efficiency, gas-phase anion size, and precursor charge state.  
In the case of CAD, as the charge state of the precursor ions increased from 5- to 
8-, the number of backbone cleavages in the form of c/y-type ions did not increase.  As a 
vibrational activation technique, CAD disrupts non-covalent bonding within the gas-
phase structure of an oligonucleotide.52  Thus, the number of observed backbone 
cleavages did not significantly decrease as the precursor charge state decreased.  
3.3.3 EDD and CAD of RNA-ligand Complexes 
Paramomycin (PM) is known to bind specifically to 16S RNA at A1408, A1492 
and A1493, as revealed by CAD of the RNA R1 analog complexed with PM.11, 43  This 
CAD approach required synthesis of the RNA analog.  Here, the feasibility of using EDD 
to detect ligand binding sites directly from the RNA-ligand complex, without the 
synthesis of RNA analogs, is evaluated.  The R1-PM complex was chosen as a model 
system for this investigation because the PM binding site was already confirmed. 
RNA R1 was mixed with PM at a 1:1 molar ratio and electrosprayed from 50% 
methanol (v/v) in water with 1% trimethylamine.  AI-EDD experiments of R1-PM 
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complexes with 6 to 8 negative charges were performed.  Observed fragments are 
mapped to the backbone, as shown in Figure 3.9. 
 
Figure 3.9.  d/w-type ions observed in AI-EDD experiments of R1-PM complexes at (a) 
6-, (b) 7-, and (c) 8- charge states.  PM binding sites derived from d/w ion series are 
circled and PM binding sites obtained previously11 are shown in the boxes. 
Compared to the AI-EDD experiments of free RNA R1, AI-EDD of R1-PM 
complexes at 6- and 7- charge states yielded less backbone fragments and PM binding 
sites could not be determined from d/w ion series.  The low fragmentation efficiency may 
be due to the noncovalent interactions introduced from ligand binding, as observed 
previously.14, 53  Here we observed that AI-EDD of R1-PM complexes at the 8- charge 
state yielded almost complete sequence coverage.  From d/w-type ions the PM binding 
site was directly localized, as shown in Figure 3.9.  However, the obtained binding site 
was not consistent with the previously reported site.11  CAD of the RNA R1 at the 6-, 7-, 
and 8- charge states yielded almost complete sequence coverage, as shown in Figure 3.10.  
However, the PM binding sites determined from CAD were also not consistent with the 
previously reported site.11 
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Figure 3.10.  c/y-type ions observed in CAD experiments of R1-PM complexes at (a) 6-, 
(b) 7-, and (c) 8- charge states.  PM binding sites obtained previously11 are shown in the 
boxes. 
From both AI-EDD and CAD of R1-PM complexes the observed binding sites 
were not consistent with results from CAD of the RNA R1 analog, X-ray crystallography, 
or cryo-electron microscopy.44-46  This result is an indication that the complexes observed 
in the mass spectra may not be due to specific binding.  The binding sites obtained from 
AI-EDD and CAD experiments may thus be from non-specific binding.  Further 
experiments, such as a systematic investigation of solvent conditions, to confirm this 
hypothesis are needed. 
Another observation was that, in CAD experiments of the R1-PM complex, c/y 
fragments containing the ligand were observed, indicating that ligand loss was 
energetically less favored than backbone dissociation.  Such strong non-covalent 
interactions have also been observed in DNA/RNA-metal complexes and DNA/RNA-
small molecule complexes.53 
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3.3.4 Correlation between Specific Binding and the RNA R1 Charge State 
As shown above, AI-EDD was only able to dissociate RNA R1 at the 8- charge 
state and higher.  Also, the binding site obtained from AI-EDD experiments was not 
consistent with the previously reported site, indicating that the R1-PM complex with 8 
negative charges may be a result of nonspecific binding.  It is reasonable to propose a 
correlation between specific binding and RNA R1 charge state.  A competitive binding 
experiment was performed to investigate this correlation.  RNA R1 has been 
demonstrated to form complexes with four aminoglycosidic ligands, including 
paromomycin (PM), (Be)kanamycin (BK), apramycin (AP), and ribostamycin (RM), as 
shown in Figure 3.11.  Binding affinities were measured by ESI-MS to be 0.11 μM, 2 μM, 
2 μM, and 16 μM, respectively.11  
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Figure 3.11. Structures of aminoglycosidic ligands: (a) paromomycin (PM), 
(b)(Be)kanamycin (BK), (c) apramycin (AP), and (d) ribostamycin (RM). 
Among the four ligands, the binding affinity order is PM > BK = AP > RM.  For a 
competitive binding experiment, a mixture containing R1, PM, BK, AP, and RM with the 
ligands at equal concentration was electrosprayed.  If all ligands bind to R1 specifically, 
the abundances of R1-ligand peaks in the mass spectrum should follow the order of 
binding affinity.  Figure 3.12 shows ESI-MS of a mixture containing 2 μM RNA R1 and 
0.1 μM of PM, BK, AP, and RM.  According to previously measured binding affinities, 
signal abundances of R1-PM, R1-BK, R1-AP, and R1-RM complexes at the same charge 
state should be at a ratio of 1:0.52:0.52:0.12.  
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Figure 3.12.  ESI-MS of RNA R1 and ligand mixture.  The mixture contained 2 μM 
RNA R1 and 0.1 μM of PM, BK, AP, and RM.  The mixture was electrosprayed in 1% 
TEA and 50% methanol in water (v/v). 
From Figure 3.12, the abundance ratio of R1-ligand complexes (with PM, BK, AP, 
and RM respectively) at the 6- charge state was 1:0.48:0.43:0.20, whereas the abundance 
ratio of R1-ligand complexes at the 7- charge state was 1:0.37:0.48 with the R1-RM 
complex not observed.  In the case of 8- and 9- charge states, only the R1-PM complex 
was observed.  As for charge states 10- and higher, no R1 complex was observed at all.  
In general, binding affinities between ligands and RNA R1 at charge states 6- and 7- were 
close to previously reported values.  Thus complexes observed at 6- and 7- charge states 
from ESI-MS of the solution with an RNA-ligand molar ratio of 20:1 are suggestive of 
specific binding.  Binding between ligands and R1 at charge states 8- and higher was 
weaker than for the 6- and 7- charge state.  This correlation between specific binding and 
charge state supports the observed difference in gas-phase structure of RNA R1 at 
different charge states (Figure 3.4).  As probed by IM-MS, RNA R1 at the 5- and 6- 
charge states is more folded than at the 8- and higher charge states.  Combining the 
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results from the competitive binding experiment and IM-MS, it is likely that RNA R1 at 
the 5- and 6- charge states is folded in its native form, and R1 at 8- and higher charge 
states is unfolded.  Little RNA-ligand formation at 8- and higher charge states also 
challenges the sensitivity of AI-EDD experiments.  In practice, AI-EDD of R1-PM 
complexes at the 8- charge state under the experimental conditions in Figure 3.12 yielded 
no detectable product ions, due to the low abundance of precursor ions. 
3.3.5 Correlation between Binding Specificity and RNA-Ligand Molar Ratio 
As shown above, R1-ligand complexation could be specific at charge states 6- and 
7-, when R1 and ligands were prepared in solution at a ratio of 20:1.  However, CAD of 
R1-PM complexes at the 6-, 7- and 8- charge states, when R1 and ligand were prepared in 
solution at a ratio of 1:1, revealed that PM binding was mostly nonspecific.  Another 
competitive binding experiment was performed to investigate the correlation between 
binding specificity and RNA ligand molar ratio in the sample solution.  Mixtures 
containing RNA R1, PM, BK, AP, and RM at different ratios were subjected to ESI-MS, 
as shown in Figure 3.13.  
81 
 
 
Figure 3.13.  ESI-MS of RNA R1 and ligand mixture.  The mixture contained 2 μM 
RNA R1 and equal molar amounts of PM, BK, AP, and RM at (left panel) 0.1 μM, 
(middle panel) 0.6 μM, and (right panel) 1.5 μM.  The mixture was electrosprayed in 1% 
TEA and 50% methanol in water (v/v). 
From Figure 3.14, the observed abundance ratio of R1-ligand complexes at the 7- 
charge state was 1:0.37:0.48 (the R1-RM complex was not observed) when R1 and 
ligands were mixed at a ratio of 20:1.  When R1 and ligands were mixed at a ratio of 10:3, 
the observed abundance ratio of R1-ligand complexes was 1:1.85:1.74:1.79 and when R1 
and ligands were mixed at a 4:3 ratio, the observed abundance ratio of complexes was 
1:1.03:1.07:0.96.  Only an R1/ligand molar ratio of 20:1 yielded observed ratios close to 
the predicted value based on previously reported binding constants.  This observation 
indicates that, as RNA ligand molar ratio decreases, nonspecific binding increases.  The 
observed correlation between binding specificity and RNA-ligand molar ratio may 
support the observation that binding sites obtained from CAD of R1-PM complexes at the 
6-, 7-, and 8- charge states were not the same as the specific binding sites previously 
reported. 
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3.4 Conclusions 
In this Chapter we first investigated the correlation between gas-phase structures 
of RNA R1 and its charge state.  IM-MS showed unfolding of R1 as the number of 
charges increases.  The transition between folded and more unfolded forms occurred 
between the 7- and 8- charge states.  When RNA R1 was electrosprayed from 50% 
methanol, R1 at the 6- charge state was observed to be folded, the 7- charge state was 
partially unfolded, and the 8- charge state appeared fully unfolded.  This trend was 
further confirmed by competitive binding experiments.  When RNA R1 was 
electrosprayed from less (30% or 10%) methanol content, R1 at the 8- charge state was 
observed folded and the 9- charge state appeared to be fully unfolded, from IM-MS. 
AI-EDD and CAD were applied to dissociate RNA R1 at different charge states.  
Sequence coverage from AI-EDD increased as the charge state of precursor ions 
increased.  Full sequence coverage was only obtained when the number of precursor ion 
charges was higher than 8.  Increased number of charges could contribute to the 
unfolding of RNA gas-phase structure and also the improvement of image current 
detection in FT-ICR-MS. 
AI-EDD and CAD were also applied to dissociate R1 complexed with the 
aminoglycosidic antibiotic drug paramomycin (PM).  The complex was electrosprayed 
from a solution containing RNA and ligand at a molar ratio of 1:1.  AI-EDD of the R1-
PM complex at the 6- and 7- charge states provided limited sequence coverage and the 
binding site could not be determined from d/w ion series.  AI-EDD of R1-PM at the 8- 
charge state provided sufficient sequence coverage to determine the binding site.  
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However, the determined binding site was not consistent with the specific binding site 
reported previously.  CAD of R1-PM at the 6-, 7-, and 8- charge states provided 
sufficient sequence coverage to locate the binding sites.  Unfortunately the determined 
binding sites were also not consistent with specific binding.  
Further competitive experiments revealed that specific binding was dependent on 
both charge state and R1-ligand molar ratio in solution.  General trends were: first, more 
charges correspond to less specific binding and, second, the more ligand in solution the 
less specific binding.  However, AI-EDD requires both relatively high precursor ion 
charge state and abundant precursor ions while, in practice, both requirements decrease 
the binding specificity, as illustrated in Scheme 3.1.  So far we have not found an 
appropriate experimental condition to obtain both good AI-EDD efficiency and good 
binding specificity.  However, further fine-tuning of experimental conditions may help 
finding a “sweet spot” to achieve both. 
 
Scheme 3.1.  Schematic summary of the correlation between AI-EDD efficiency, binding 
specificity, precursor charge state, and ligand amount in the electrospray solution. 
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Overall, given the correlation between AI-EDD efficiency, binding specificity, 
precursor charge state, ligand amount in electrospray solution, and the organic solvent 
content, care should be taken when ESI-MS and AI-EDD are applied for the investigation 
of RNA-ligand complexes to avoid nonspecific binding. 
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Chapter 4 
Top-down MS/MS of Proteins in Negative Ion Mode 
 
4.1. Introduction 
The development of modern mass spectrometers together with the rapid advances 
in genome sequencing have enabled the field of proteomics.  Two complementary 
approaches, i.e.,“bottom-up”1 and “top-down”2, 3 analysis have evolved for proteomic 
research.  The more widely utilized bottom-up approach targets peptides with masses less 
than a few kDa.  Such peptide mixtures are either naturally present or generated by 
protease digestion.  Top-down proteomics, on the other hand, involves introduction of 
undigested proteins into the mass spectrometer.  Masses of whole proteins are measured 
and further dissociation of protein ions (tandem mass spectrometry or MS/MS) provides 
structural information.  Several MS/MS strategies are employed in top-down proteomics, 
including collision activated dissociation (CAD),4-9 infrared multiphoton dissociation 
(IRMPD),10 blackbody infrared radiative dissociation (BIRD),11, 12 electron capture 
dissociation (ECD),13-16 and electron transfer dissociation (ETD).17  The three former 
techniques are referred to as “slow-heating” methods18 because activation of precursor 
ions is achieved by accumulation of energy from multiple collisions with collision gas 
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molecules or from absorption of multiple infrared photons.  Due to intramolecular 
vibrational energy redistribution (IVR),19 vibrational energy gained from collisions or 
from photon absorption is redistributed to thermodynamically favored fragmentation 
pathways.  Thus, facile losses of labile post-translational modifications (PTMs) 
frequently dominate MS/MS spectra of peptides.20  For example, for peptides 
phosphorylated on serine or threonine, abundant loss of phosphate and/or phosphoric acid 
is observed.21, 22  There are examples showing that labile PTM loss is less frequent when 
intact proteins (>9 kDa) are fragmented.23, 24  This difference between bottom-up and top-
down analysis may be due to gas-phase protein higher-order structures that stabilize 
PTMs and thus favor fragmentation at backbone amide bonds rather than PTM loss.25  In 
contrast to vibrational activation of even-electron protein ions, ECD involves gas-phase 
radical ion chemistry13, 26 following capture of low-energy electrons (<2 eV) by multiply 
protonated peptide and protein ions.  Backbone N-Cα bonds are cleaved to produce c and 
z•-type ions without loss of PTMs.27-29  Analogous fragmentation behavior is observed in 
electron transfer dissociation (ETD), which also involves radical intermediates but from 
ion-ion reactions.30 
Phosphorylation is one of the most common PTMs and plays critical roles in 
various biological processes such as cell signaling.31  Top-down proteomics provides 
benefits in the characterization of phosphoproteins, including determination of 
phosphorylation sites, and possible quantification of site-specific phosphorylation.32, 33  
ECD and ETD, in particular, provide extensive backbone cleavages without phosphate or 
phosphoric acid loss.28, 30, 34   
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To date, the vast majority of top-down approaches involves positive ion mode in 
which proteins are typically electrosprayed in acidified solvent.  Protein N-termina and 
basic amino acid residues are protonated or become protonated during the electrospray 
process.  However, for phosphorylated proteins, the high acidity of phosphate affects the 
overall protonation following electrospray ionization.  Furthermore, salt bridges may 
form between negatively charged phosphates and protonated groups if favorable steric 
configurations exist.35, 36  Because ECD at conventional low electron energies does not 
disrupt non-covalent interactions,37-39 backbone cleavages near phosphorylated sites may 
not be observed.  Lack of such cleavages is unfortunate because they are frequently 
required to precisely assign phosphorylation sites.  Higher electron energy can improve 
ECD efficiency, presumably by disrupting noncovalent bonds and unfolding 
peptide/protein gas-phase structure.36  Alternatively, an infrared laser pulse or collisions 
with neutral gas before or after electron irradiation may unfold the gas-phase protein 
structure and consequently increase ECD backbone cleavage coverage, an approach 
termed “activated ion” ECD (AI-ECD).40, 41  In “plasma” ECD,42 protonated protein 
cations are activated by gas collisions.  In addition, electrons are decelerated and forced 
to travel in the same direction as the precursor ions to maximize the cross-section of the 
ion-electron reaction.  However, even after AI-ECD or plasma ECD, backbone cleavages 
near phosphorylated sites are scarcer than in non-phosphorylated protein regions.42  
Negative ion mode, in which proteins are typically electrosprayed in basic solvent, 
promotes deprotonation of protein C-termina, acidic PTMs, acidic amino acid residues, 
and, to a certain extent, backbone amides.  In regions with multiple acidic PTMs or acidic 
amino acid residues, electrostatic forces may contribute to unfolding of the local 
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noncovalent tertiary structure, thus potentially enhancing the observation of backbone 
cleavages from such regions compared to positive ion mode.  Formation of salt bridges 
may also be circumvented because protonation is suppressed by the basic electrospray 
solvent.  In bottom-up approaches, CAD and IRMPD have been demonstrated to generate 
useful structural information for deprotonated peptides.43-47  However, vibrational 
activation of peptide anions typically results in abundant internal fragments, neutral 
losses, and side chain losses, in addition to the backbone cleavages that dominate in 
positive ion mode.45, 47  Thus, MS/MS spectra are more complex and less useful structural 
information is generated in negative ion mode.  Electron detachment dissociation 
(EDD),48 operates in negative ion mode and involves higher electron energy (>10 eV) 
than ECD.  EDD has been shown to yield mainly a• and x-type product ions for peptides 
and proteins,48-50 mainly d and w-type ions for nucleic acids,51-54 and extensive glycosidic 
and cross-ring fragments for oligosaccharides.55, 56  However, one drawback of EDD of 
polypeptides is its low fragmentation efficiency, compared to other fragmentation 
methods.57   
Top-down analysis of large biomolecules in negative ion mode has only recently 
begun to be explored.  Taucher and Breuker reported ~90% sequence coverage for an 
18.2 kDa ribonucleic acid in negative ion CAD52 and McLuckey and co-workers 
demonstrated ~60% sequence coverage for a 25 kDa intact tRNA.58  Very recently, 
Breuker and co-workers explored EDD for top-down protein analysis and reported ~19% 
sequence coverage for an acidic 147-residue protein.50  However, to our knowledge, 
negative ion top-down analysis of proteins with acidic modifications, including 
phosphorylation and glycosylation has not previously been explored.  Here we employ 
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negative ion IRMPD and AI-EDD for top-down analysis of three proteins, including 
multiply phosphorylated β-casein, the acidic protein calmodulin, and glycosylated 
ribonuclease B.  
4.2. Experimental Section 
4.2.1. Sample Preparation 
For negative ion mode electrospray ionization (ESI), protein solvent consisted of 
0.2% v/v piperidine (Sigma-Aldrich, St. Louis, MO) in 1:1 v/v HPLC grade water (Fisher 
Scientific, Fair Lawn, NJ) /HPLC grade methanol (Fisher Scientific, Fair Lawn, NJ).  For 
positive ion mode ESI, the solvent was 0.5% v/v formic acid (Acros Organics, Morris 
Plains, NJ) in 1:1 v/v water/methanol.  β-casein from bovine milk, calmodulin from 
bovine testes, and RNase B from bovine pancreas (Sigma-Aldrich) were dissolved 
separately into electrospray solution and infused via an Apollo II electrospray ion source 
at 60 µL/h.  
4.2.2. Mass Spectrometry 
Mass spectra were obtained with a 7-T quadrupole-FT-ICR mass spectrometer 
(Bruker Daltonics, Billerica, MA).  IRMPD experiments were performed with a vertically 
mounted 25 W, 10.6µm, CO2 laser (Synrad, Mukilteo, WA).  Photon irradiation was 
performed at 50% laser power with two different pulse sequences,: either one 200-300 ms 
pulse or multiple 15 ms pulses with a 200 ms delay between each pulse.  IRMPD peak 
assignments are based on the combination of spectra from two pulse sequences.  AI-EDD 
experiments were performed in the ICR cell by irradiating protein anions with a 20 ms IR 
laser pulse (50% power) followed by 20-30 eV electron irradiation for 1 second.  
Electrons were generated by a hollow cathode.  AI-ECD experiments were performed by 
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irradiating protein cations with a 20 ms  IR laser pulse (50% power) followed by 0.01 eV 
electrons for 0.5-1 s. 
Raw spectra were acquired with Bruker XMass software and summed over 256 or 
512 scans.  Spectra were processed by DataAnalysis 4.0 software (Bruker Daltonics) and 
peaks were assigned by a combination of manual assignment and an in-house written 
Microsoft Excel macro.  
4.3. Results and Discussion 
4.3.1. Infrared Multiphoton Dissociation of β-casein Anions 
 
Figure 4.1. (a) Negative ion IRMPD of all observed charge states (15- to 26-) of β-casein 
anions generated by electrospray ionization.  Inset: partial IRMPD spectrum.  Noise 
peaks are labeled with asterisks.  (b) AI-EDD of all observed charge states of β-casein 
anions generated by electrospray ionization.  Only a-type fragments are labeled.  Spectra 
are summed over 256 scans.  (c) Fragmentation map from (a).  (d) Fragmentation map 
from (b).  Only the first 22 amino acids are shown.   
 
Figure 4.1a shows negative ion IRMPD of β-casein anions.  Intact β-casein was 
electrosprayed at 0.1 mg/mL from a solution containing 1:1 v/v water/acetonitrile with 
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0.25% piperidine and all charge states were irradiated with a 180 ms laser pulse (7.5 W).  
IRMPD of the individual charge states 15- and 22- yielded virtually identical spectra but 
with lower signal to noise ratio than IRMPD of all charge states.  N-terminal b and c-type 
ions dominate the IRMPD spectrum, as summarized in Figure 1c, but extensive internal 
fragments were also observed.  The overall sequence coverage was 7% (15 backbone 
cleavages out of 208).  However, extensive fragmentation was observed within the region 
Glu-14 to Glu-21, which contains seven acidic or phosphorylated side chains out of eight 
amino acids.  Glu-14 to Glu-21 has a pI of 1.6 as predicted by Scansite Molecular Weight 
and Isoelectric Point Calculator (http://scansite.mit.edu/cgi-bin/calcpi).  Partial phosphate 
loss is observed for both b-type and c-type ions.  Phosphorylation sites at Ser-15, Ser-17, 
Ser-18, and Ser-19 are clearly identified by c-type fragments and a combination of b and 
b - H3PO4-type ions also provides identification of phosphorylation sites at Ser-15, Ser-
17, and Ser-18.   
4.3.2. Activated Ion Electron Detachment Dissociation of β-casein Anions 
AI-EDD of β-casein anions is shown in Figure 1b.  All observed charge states 
were irradiated with a 90 ms IR laser pulse (7.5 W), followed by a beam of ~19 eV 
electrons for 1s.  AI-EDD of β-casein yields predominantly a-type radical ions 
corresponding to backbone cleavage close to the N-terminus, as shown in Figure 1d.  The 
EDD fragmentation mechanism for peptides has beeninvestigated by Kjeldsen, et al. and 
Anusiewicz, et al. by computational approaches.59, 60  In their work it was proposed that 
negative charges are located on backbone nitrogen atoms and that electron ejection 
occurs from such deprotonated backbone nitrogens.  These authors showed that formation 
of a/x• product ions is both thermodynamically and kinetically less favored than 
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formation of a•/x product ions.  In a recent investigation of protein EDD  a/x• product 
ions were not reported50 and such product ions are also dominant in the work presented 
here.  However, even-electron ions a4, a9 and radical x2•, x3• ions were also observed in 
our EDD spectra.  One hypothesis is that even-electron a-type ions are from hydrogen 
transfer events, similar to those observed in ECD61, 62.  Another hypothesis is that, even 
though formation of a/x• product ions is less favored, it is still statistically possible, 
noting that electron irradiation time in our experiments was 1 s, rather than the 100-300 
ms used by Ganisl et al.50  Neutral CO2 loss, which was reported as a major 
fragmentation pathway by Ganisl et al., was not observed in our experiments, even for 
product ions with terminal glutamic acid residues.  However, the product ion abundance 
in our experiments was rather low and thus fragments corresponding to CO2 loss may be 
below our detection limit.  Ganisl et al., also reported that a•/x product ion formation was 
facilitated by neighboring basic residues.  However, the fragments observed in our study 
did not result from cleavage near lysine or arginine.  Compared to negative ion IRMPD, 
AI-EDD provides less sequence coverage, ~5% (10/208 backbone cleavages observed).  
However, the total number of peaks in the AI-EDD spectrum corresponds to 28% of the 
number of peaks (with an S/N ratio >2) in the IRMPD spectrum.  13% of the peaks in the 
AI-EDD spectrum are sequence informative compared to 5% in IRMPD.   Thus, AI-EDD 
results are more facile to interpret.  The simplicity of EDD spectra and the specificity of 
a-type backbone cleavage appear advantageous compared to IRMPD although EDD 
fragmentation efficiency is low.  
4.3.3. Comparison between Negative and Positive Ion Mode 
96 
 
Positive ion IRMPD and AI-ECD were applied to β-casein for comparison with 
the negative ion results.  Positive ion IRMPD cleaved 21 backbone amide bonds, with 
extensive internal fragments, water losses, and phosphoric acid losses.  Under our 
instrumental conditions, AI-ECD cleaved 26 backbone amine bonds.  The combination of 
IRMPD and AI-ECD provided 29 backbone cleavages.  Previously reported AI-ECD and 
plasma ECD of intact β-casein provided 87 backbone cleavages.34  In negative ion mode, 
the combination of AI-EDD and IRMPD yielded 20 backbone cleavages.  As shown in 
Figure 4.2, AI-EDD and negative ion IRMPD provided nine unique backbone cleavages 
compared to AI-ECD and positive ion IRMPD.  In particular, negative ion IRMPD 
yielded extensive fragmentation within the highly acidic region Glu-14 to Glu-21.  Four 
phosphorylated sites were directly identified by backbone cleavages in this region.  The 
latter analysis was not feasible in positive ion mode with our instrument, nor from 
previously published AI-ECD.34  Plasma ECD data42 located all phosphorylation sites; 
however, it did not provide backbone cleavages between each phosphorylated residue. 
Figure 4.2.  Comparison of β-casein fragmentation patterns in negative and positive ion 
mode.  All backbone cleavages from AI-EDD and negative ion IRMPD are labeled 
‘negative’ and all backbone cleavages from AI-ECD and positive ion IRMPD are labeled 
‘positive’. 
 
97 
 
Calmodulin (pI = 4.0) and glycosylated ribonuclease B (RNaseB, pI = 8.6) were 
also investigated in both positive and negative ion top down MS/MS.  For calmodulin, 
AI-ECD and positive ion IRMPD provided 40 backbone cleavages out of 148 possible 
peptide bonds.  AI-EDD and negative ion IRMPD yielded an additional six backbone 
cleavages, as shown in Figure 4.3. 
 
Figure 4.3.  Comparison of calmodulin fragmentation patterns in negative and positive 
ion mode.  All backbone cleavages from AI-EDD and IRMPD in negative ion mode are 
labeled ‘negative’ and all backbone cleavages from AI-ECD and IRMPD in positive ion 
mode are labeled ‘positive’. 
 
For RNase B, AI-ECD and positive ion IRMPD provided 41 backbone cleavages 
out of 124 possible peptide bonds whereas AI-EDD and negative ion IRMPD yielded an 
additional two backbone cleavages, as shown in Figure 4.4. 
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Figure 4.4.  Comparison of RNase B fragmentation patterns in negative and positive ion 
mode.  All backbone cleavages from AI-EDD and IRMPD in negative ion mode are 
labeled ‘negative’ and all backbone cleavages from AI-ECD and IRMPD in positive ion 
mode are labeled ‘positive’. 
 
A summary of observed negative and positive ion mode fragmentation for all 
three proteins is shown in Figure 4.5.  For β-casein and calmodulin, which are both acidic 
proteins, negative ion dissociation, particularly IRMPD, provides more complementary 
sequence information than for the basic protein RNase B.  AI-EDD of β-casein, 
calmodulin and RNase B yielded similar numbers of backbone a•/x ions.  In all three 
cases backbone cleavages were mainly observed close to the protein termini.  Kjeldsen et 
al. reported that EDD backbone cleavages in peptides are favored near acidic residues.60  
By contrast, such a preference was not observed in EDD of the proteins ubiquitin and 
melittin.50  In our work, the largest a• ion observed from β-casein was a•16.  For this 
protein, 11 of the first 16 (i.e., 69%) possible backbone cleavages, counting from the N-
terminus, represent cleavage N- or C-terminal to acidic residues (D, E and pS).  Among 
the observed eight backbone cleavages in this region, five (i.e., 63%) represent backbone 
cleavage close to acidic residues.  For calmodulin, 62% of the first 13 possible backbone 
cleavages are close to acidic residues and, among the observed nine backbone cleavages, 
56% are close to acidic residues.  For RNase B, 50% of the first 16 possible backbone 
cleavages are close to acidic residues and, among the observed nine backbone cleavages, 
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33% are close to acidic residues.  Thus, for these proteins a cleavage preference near 
acidic residues was not apparent.  However, a general analysis was hampered by the low 
sequence coverage.  As for the previously mentioned proposed favored cleavage near 
basic residues50 all three proteins investigated here contain similar total numbers of K and 
R residues: 15, 14 and 14, respectively.  The total numbers of a•/x-type backbone bond 
cleavages were similar as well (10, 9, and 10, respectively).  Further, the N-terminal 
regions of these three protein sequences contain few K and R residues.  Thus, a clear 
correlation between a•/x cleavage and the presence of basic residues is difficult to derive.  
 
Figure 4.5. Comparison of the numbers of backbone cleavages in negative and positive 
ion mode top down MS/MS of (a) β-casein; (b) calmodulin; and (c) RNase B. 
 
4.4. Conclusions 
Top-down protein analysis in negative ion mode was investigated by employing 
two dissociation techniques on three intact proteins.  In general, negative ion IRMPD and 
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AI-EDD provided complementary sequence information compared to positive ion 
IRMPD and AI-ECD.  However, less overall sequence coverage was seen in negative ion 
mode.  More complementary fragments were observed in negative ion mode for the 
acidic proteins β-casein and calmodulin than for the basic protein RNase B.  A possible 
explanation for this observation may be that salt-bridge formation, which can reduce the 
observation of backbone fragments, is favored in positive ion mode for acidic proteins.  
In particular, IRMPD of β-casein, with multiple phosphorylated sites close to each other, 
yielded backbone cleavages between the first four phosphorylated amino acids from the 
N-terminus.  Such cleavages, which are essential to precisely locate phosphorylation sites, 
were not observed in positive ion IRMPD nor AI-ECD but were partially observed in 
previous plasma ECD.42 
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Chapter 5 
Characterization of Oligonucleotides by Negative Ion Electron Capture 
Dissociation Fourier Transform Ion Cyclotron Resonance Mass 
Spectrometry 
 
5.1 Introduction 
Mass spectrometry (MS) and tandem mass spectrometry (MS/MS) have been 
well-developed and applied to the determination of nucleic acid sequence.1-3  Commonly 
employed MS/MS strategies are based on vibrational activation, or “slow-heating”, such 
as collision activated dissociation (CAD),4 infrared multiphoton dissociation (IRMPD),5 
and blackbody infrared radiative dissociation (BIRD).6  Signature (a - B) and w-type ions 
(McLuckey nomenclature7) are observed for the sequencing of oligodeoxyribonucleotides 
(DNA), whereas, for oligoribonucleotides (RNA), sequence-specific c and y-type ions are 
observed.  Despite the wide-spread use of “slow-heating” techniques, one major 
disadvantage is extensive neutral loss, such as water and nucleobase loss.  These losses 
spread available signal over multiple peaks, which complicates spectrum interpretation 
and lowers sensitivity.  
Gas-phase ion-electron reactions such as electron capture dissociation (ECD)8 in 
positive ion mode and electron detachment dissociation (EDD)9 in negative ion mode 
have been developed as alternatives to vibrational activation techniques.  In ECD, 
multiply charged cations are irradiated with low energy electrons (< 1 eV) and capture 
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electrons to form radical intermediates that further dissociate into fragments.  ECD has 
been applied to, e.g., peptides,8, 10 proteins,8, 11 oligonucleotides,12, 13 polymers,14 
carbohydrates,15, 16 lantibiotics,17 and peptide nucleic acids.18  ECD can retain labile 
modifications such as peptide phosphorylation19, 20 and glycosylation21, 22 that are 
preferentially lost in slow-heating MS/MS activation methods.  ECD of multiply 
positively charged DNAs has been demonstrated to generate sequence-specific w/d and 
a•/z•-type ions12 with significantly reduced neutral loss compared with CAD and IRMPD.  
The lower degree of neutral loss simplifies spectrum interpretation.2  Initial application of 
ECD to DNA analysis was performed with an FT-ICR mass spectrometer equipped with 
a directly heated filament.  This configuration resulted in limited product ion abundance.  
Improved fragmentation efficiency was obtained via IR-activated MS3 of the radical 
intermediate, similar to the case of phospho23 and glycopeptides.24  An alternative 
approach is IR or collisional activation of the isolated precursor ion prior to electron 
irradiation.25, 26  More significant improvement of fragmentation efficiency was achieved 
by switching to an indirectly heated ring cathode with an increased cross-section, thus 
generating improved overlap between the electron cloud and cations in the ICR cell.13  
Nevertheless, due to the acidity of the phosphate backbone, oligonucleotides are detected 
with lower sensitivity in positive ion mode, compared with negative ion mode.  EDD, 
which operates in negative ion mode, benefits from this higher ionization efficiency.  In 
EDD, multiply charged anions are irradiated with energetic electrons (typically between 
15 and 30 eV), resulting in ejection of electrons to form radical intermediates that further 
dissociate.27  EDD has been applied to peptides,9 carbohydrates,28-30 and nucleic acids.31-
33  EDD of multiply charged DNA oligomers has been demonstrated to generate similar 
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types of fragments as ECD31 whereas  EDD of multiply charged RNA oligomers (6- to 
10-mers) has been shown to produce c-, y-, d- and w-type ions.34  EDD of larger RNAs 
(34- to 61-mers) provided evidence that c- and y-type ions may result from vibrational 
activation, such as collisions during the ion transfer process, or charge state-dependent 
structural relaxation.33  Both ECD and EDD require precursor ions to be multiply charged 
and are thus not applicable to singly charged ions. 
Recently, our group has demonstrated that electrons within a certain energy range 
can be captured by singly charged peptide anions.35  Moreover, ECD-like fragments were 
observed following the electron capture event.  Fragments from investigated 
phosphorylated peptides retained phosphate during the dissociation process.  This new 
dissociation technique was named negative ion electron capture dissociation (niECD).35  
Several doubly deprotonated peptides were also fragmented by niECD.  Gas-phase 
zwitterionic structures were proposed to be important for successful niECD of peptides.  
This hypothesis was supported by the observation of increased or decreased niECD 
efficiency upon alteration of the peptide N-terminus by adding a fixed charge tag (to 
promote zwitterion formation) or acetylation  (to reduce zwitterion formation).  Also, it 
has been shown that gas-phase zwitterionic structures are favored for phosphopeptides36, 
37 which undergo efficient niECD.  Oligonucleotides contain acidic phosphate backbones 
and basic nucleobases, a composition that may favor gas-phase zwitterion formation.  
Molecular modeling of mononucleotides suggested that protonation of nucleobase 
nitrogens is more favored than the non-bridging phosphate oxygens, except for T/U.38  It 
has been demonstrated that zwitterion formation is possibly favored when 
oligonucleotides are electrosprayed from ammonium-based buffers.39  Further, several 
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proposed mechanisms for (a - B)/w-type ion formation from vibrational activation 
involve a zwitterion intermediate.40-42  One proposed mechanism for d/w-type ion 
formation in EDD of RNA also involves a zwitterionic radical intermediate.33  If 
oligonucleotides are zwitterionic in the gas-phase they may undergo efficient niECD, 
similar to phosphopeptides.  Here we explore the application of niECD to deprotonated 
oligonucleotides.   
5.2 Experimental Section 
5.2.1 Sample Preparation 
All oligonucleotides were purchased from Integrated DNA Technologies, Inc. 
(Coralville, IA).  6-mer and 11-mer DNA and RNA were dissolved in electrospray 
solution (1% triethylamine in 50% (v/v) H2O, 25% methanol and 25% isopropyl alcohol) 
and electrosprayed without further desalting.  The 27-mer RNA 16S R1 (5’-
GGCGUCACACCUUCGGGUGAAGUCGCC-3’) was desalted by ethanol precipitation 
(protocol modified from Limbach et al.43). 1 nmole of RNA was mixed with 20 μL of 7.5 
M NH4OAc and 80 μL of cold ethanol.  The mixture was vortexed, stored at -80 °C for 3 
hours, centrifuged for 30 minutes and the supernatant was discarded.  200 μL of 90% 
cold ethanol was added to the precipitate and stored at - 80 °C for 2 hours.  The mixture 
was centrifuged at 12,000 g for 30 minutes and the supernatant was discarded.  The 
precipitate was dissolved in electrospray solution (10 mM NH4OAc in 50% (v/v) H2O, 50% 
isopropyl alcohol) for electrospray ionization. 
5.2.2 Mass Spectrometry 
All mass spectra were acquired with a 7-T quadrupole-FT-ICR mass spectrometer 
(Apex-Q, Bruker Daltonics, Billerica, MA).  The oligonucleotide solutions were infused 
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via an Apollo II electrospray ion source at a flow rate of 70 μL/hour.  Ions with mass to 
charge ratios of interest were selected by the external quadrupole, accumulated in a 
hexapole, and transported to the ICR cell for further activation and dissociation.  niECD 
experiments were performed in the ICR cell by irradiating precursor ions for 3-5 seconds 
with an electron beam generated by an indirectly heated hollow dispenser cathode.  
Electron energy and number were controlled by adjusting the voltages on the cathode and 
the focusing lens located between the cathode and the ICR cell.  The cathode bias voltage 
was in the range - 6 to - 10 V and the lens voltage was in the range - 4.5 to - 8.5 V.  
Electron energy distributions were measured by monitoring the current impinging on the 
focusing lens located on the opposite side of the ICR cell compared with the cathode 
while changing the voltage of the cathode and the focusing lens.  For activated ion (AI) 
niECD experiments, precursors ions in the ICR cell were irradiated with an infrared laser 
beam from a 25-W, 10.6-μm, CO2 laser (Synrad, Mukilteo, WA) at 50% power for 20-50 
ms, prior to irradiation with the electron beam.  For niECD-IRMPD experiments, a 
correlated harmonic excitation field (CHEF)44 waveform was applied after the niECD 
event to eject all ions within the detection range except the charge-increased product ions, 
then the isolated charge-increased ions were irradiated with an infrared laser for 2-5 s at 
12.5 W.  Mass spectra were acquired with XMASS (version 6.1, Bruker Daltonics) in 
broadband mode from m/z 200 to 3000 and analyzed by DataAnalysis (version 4.0, 
Bruker Daltonics).  Product ions were assigned within 10 ppm mass accuracy. 
5.3 Result and Discussion 
5.3.1 Electron Capture of RNA Hexamers (rGCAUAC, rA6, rC6, rG6 and rU6) 
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When the singly deprotonated oligoribonucleotide 5’-GCAUAC-3’ (denoted as 
[M - H]-) was irradiated with 4.2 eV electrons for 5 seconds, a dominant product ion peak 
with an m/z ratio corresponding to [M - H]2-• was observed, as shown in Figure 5.1.  The 
isotopic distribution of this peak matches with the calculated distribution for this radical 
species.  The high abundance of this peak indicates that it is not an artifact at twice the 
ICR frequency of the precursor ions.  Also, this isotopic cluster could be further isolated 
in the ICR cell, as shown in the following section.  Electron detachment from 
oligonucleotide anions has been reported through ion-electron,31 ion-photon,45 and ion-
ion46-49 reactions.  However, to our knowledge, the result presented here is the first 
observation of electron capture by oligonucleotide anions.  rA6, rC6, rG6, and rU6 were 
also subjected to irradiation with electrons of the same energy, as shown in Figure 5.2.  In 
the cases of rA6 and rG6, [M - H]2-• was the most abundant product ion whereas, for rC6, 
[M - H2O - H]2-• and [M - H]2-• were the most abundant product ions.  For rU6, (w5 + 
2H)2- and (w5 + 2H + H2O)2- were the most abundant product ions but [M - H2O - H]2-• 
and [M - H]2-• were also observed in lower abundance. (w5 + 2H)2- and (w5 + 2H + H2O)2- 
could also be assigned as [M - 2U - 2H]2- and [M - 2U + H2O - 2H]2-. In ECD of rC6 
cations, water loss was not observed.34  Water loss in niECD of rC6 anions may result 
from structural unfolding due to the charge state increase.  Another observation was that 
backbone fragmentation was limited in niECD of all hexamer oligonucleotides.  Similar 
behavior has been reported in ECD of doubly protonated DNA: under conditions for 
which most peptides were efficiently dissociated, the dGCATAC dication only captured 
electrons to form charge-reduced radical species with limited further dissociation.12, 13  
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Further activation, prolonged electron irradiation time, or more electrons injected into the 
ICR cell were necessary to improve ECD fragmentation efficiency.24, 50, 51 
 
Figure 5.1.  Electron capture by rGCAUAC.  Singly deprotonated precursor anions were 
irradiated with 4.3 eV electrons for 5 seconds.  In the inset, circles illustrate the 
calculated isotopic distribution of [M - H]2-• anions. 
 
 
 
Figure 5.2.  niECD of RNA hexamers: (a) rA6, (b) rG6, (c) rC6, (d) rU6.  Singly 
deprotonated precursor anions were irradiated with 4.3 eV electrons for 3 seconds. 
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In order to understand the energy dependence of the anion electron capture 
process, the yield of charge-increased species from electron irradiation at different 
energies was investigated.  This yield was calculated as the ratio between the abundance 
of charge-increased species (divided by charge state) and the precursor ion abundance 
prior to electron irradiation.  For rA6 and rG6, the charge-increased species was [M - H]2-•. 
For rC6 and rU6, the charge-increased species was the sum of [M - H]2-• and [M - H2O - 
H]2-•.  Electron capture efficiency for rA6 is shown in Figure 5.3 (a) and electron capture 
efficiencies for rA6, rG6, rC6, and rU6 are shown in Figure 5.4.  For rA6, maximum 
efficiency was achieved at 4.2 eV with a full width at half maximum (FWHM) of 1.2 eV.  
For the utilized hollow cathode implemented on the instrument, the FWHM of the 
electron energy distribution is 0.6 eV at 4.2 eV.  Considering this uncertainty in the 
electron energy, the accepted energy range for rA6 anion electron capture may be less 
than 4.2±1.2 eV.  For rG6, rC6, and rU6, maximum electron capture efficiencies were 
achieved at 4, 3.7, and 3.4 eV, respectively.  A comparison of these maximum 
efficiencies is shown in Figure 5.3 (b).  All maximum efficiencies are around 4 eV and 
the differences are within the FWHM, indicating that electron capture efficiency does not 
have a significant nucleobase dependence. 
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Figure 5.3.  Electron capture efficiencies for different oligoribonucleotides.  (a) Yield of 
charge-increased species from electron capture by rA6.  Maximum electron capture 
efficiency was observed at 4.2 eV.  (b) Comparison of electron energies for which 
maximum electron capture efficiency was observed for rA6, rG6, rC6, and rU6.  Error bars 
correspond to half of the FWHM of, e.g., the peak in (a). 
 
 
Figure 5.4. Electron capture efficiencies for RNA hexamers: (a) rA6, (b) rG6, (c) rC6, (d) 
rU6.  Electron capture efficiency was calculated as the ratio between the abundance of 
charge-increased species (divided by charge state) and the precursor ion abundance prior 
to electron irradiation.  For rA6 and rG6, the charge-increased species was [M - H]2-•. For 
rC6 and rU6, the charge-increased species was the sum of [M - H]2-• and [M - H2O - H]2-•.   
 
 
5.3.2 Electron capture by RNA 11- and 27-mer 
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When the doubly deprotonated RNA rUAACUAUCACG ([M - H]-) was 
irradiated with 4.2 eV electrons, [M - 2H]3-• was observed as the dominant product ion 
with limited occurrence of other product ions, as shown in Figure 5.5.  Irradiation of the 
five times deprotonated 27-mer RNA rGGCGUCACACCUUCGGGUGAAGUCGCC 
([M - 5H]5-) with 8.4 eV electrons resulted in observation of [M - 5H]6-• as the dominant 
product ions, as shown in Figure 5.6.  The experimentally observed isotopic distribution 
of [M - 5H]6-• was compared with the isotopic distribution of [M - 6H]6- from electrospray 
ionization on the same instrument, as shown in the inset of Figure 5.6.  This comparison 
lends further support that the product ion is a radical from electron capture rather than an 
even-electron species.  For the 27-mer RNA, higher electron energy was required for 
electron capture to occur, compared with the 11-mer and the hexamers, possibly due to 
the higher Coulomb repulsion. 
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Figure 5.5.  Electron capture by UAACUAUGACG in its 2- charge state following 
irradiation with 4.5 eV electrons for 6 s. 
 
 
Figure 5.6.  Electron capture by rGGCGUCACACCUUCGGGUGAAGUCGCC in its 5- 
charge state following irradiation with 8.4 eV electrons for 3s.  The inset shows the 
isotopic distribution of the observed [M - 5H]6-• overlaid with [M - 6H]6- from 
electrospray ionization on the same instrument. 
 
5.3.3 niECD-IRMPD (MS3) and AI-niECD of rGCAUAC Anions 
Electron capture by singly deprotonated rGCAUAC (Fig. 5.1) yielded limited 
backbone fragmentation.  As shown in Figure 5.7, further activation of [M - H]2-• by 
infrared laser irradiation promoted more fragmentation.  For IRMPD MS3, doubly 
charged radicals produced from electron capture were activated by IR laser irradiation at 
12.5 W for 10 seconds.  d-, w-, c-, and y-type ions were most common among the 
observed product ions.  Complete d/w-type ion series, except for d2 and w5, were detected.  
Four out of 10 possible c/y-type ions were observed.  Compared with the EDD spectrum 
of doubly deprotonated rGCAUAC, niECD-IRMPD of the singly deprotonated form of 
the same RNA provides the same number of d/w-type ions but less c/y-type ions, which 
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may simplify spectrum interpretation.  As an alternative to niECD-IRMPD, IR activation 
can be applied before electron irradiation (denoted as activated ion niECD or AI-niECD).  
In AI-niECD of rGCAUAC, precursor ions were irradiated with IR photons at 12.5 W 
laser power for 40 ms and then with 3.5 eV electrons for 3 s.  d1, d2, d5, w2, w3, w4, and w5 
ions were identified, as shown in Figure 5.8.  The optimum electron energy of 3.5 eV in 
AI-niECD is lower than the 4.5 eV used for the electron capture experiment, possibly due 
to the lower stability of precursor ions after IR activation.  A minor precursor ion 
corresponding to loss of one adenine base was also observed from IR activation.  
Compared with niECD-IRMPD, AI-niECD offers less total activation time and dominant 
d/w-type product ions, however the fragmentation efficiency in AI-niECD was lower. 
 
Figure 5.7.  MS3 (niECD-IRMPD) of singly deprotonated rGCAUAC.  4.5 eV electrons 
were used for 4 s.  Electron capture species were activated by IR laser irradiation at 12.5 
W for 4 seconds.  
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Figure 5.8.  AI-niECD of singly deprotonated rGCAUAC.  IR activation was at 12.5 W 
laser power for 40 ms.  In the following niECD event 3.5 eV electrons were used for 3 s.   
 
 
5.3.4 niECD-IRMPD of rA6, rG6, rC6, and rU6 Anions and dA6, dG6, dC6, and dT6 
Anions 
 
Similar to the RNA rGCAUAC, the RNAs and DNAs A6, G6, C6, and U6 (T6) 
were subjected to niECD-IRMPD (MS3).  The electron capture step was performed by 
irradiating singly deprotonated precursor ions with 3.5-4.2 eV electrons for 3-5 s.  
IRMPD (MS3) was performed by irradiating [M - H]2-• with an IR laser at 12.5 W for 4-
10 s.  Identified fragments are summarized in Table 5.1, except for nucleobase and water 
loss from precursor ions.  For the RNAs investigated, d/w-type ions were more abundant 
than c/x-and b/y-type ions.  a/z-type ions were not detected.  Nucleobase and water loss 
from backbone fragments were not observed either.  For the DNAs investigated, d/w-type 
ions were more abundant than c/x- and a/z-type ions.  b/y-type ions were not detected.  
Nucleobase loss was observed for some of the c/x- and a/z-type ions.  Compared with 
EDD,31, 34 niECD-IRMPD yields similar types of ions and similar fragmentation 
efficiency, despite the fact that the intermediate species in EDD is [M - 2H]-• rather than 
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[M - H]2-•.  This similarity may be due to similar initial gas-phase structures of the 
precursor ions as both techniques utilize anionic precursor ions.  Compared with ECD of 
oligodeoxynucleotides,12, 13, 31 niECD-IRMPD yields complete d/w-type ion series, as 
well as less abundant a/z- and c/y- type ions.  This product ion pattern simplifies 
spectrum interpretation.  In the case of dC6, niECD-IRMPD provided (a3/z3 + H)• and 
(a5/z5 + H)• ions, which  have previously been observed12 in ECD of dC6.  niECD-
IRMPD also provided an (a2 - H)• ion, which has been previously observed in EDD of 
dC6.31  In the case of dT6, niECD-IRMPD provided “ECD-like” (a2 + H)• , (a4 + H)• and 
(a5 + H)•, ions.  However, due to the low proton affinity of thymine nucleobases, ECD of 
dT6 has not been reported and thus a direct comparison between niECD-IRMPD and 
ECD of dT6 is not possible.  niECD-IRMPD of dT6 also provided (a2 - H)• and (a4 - H)• 
ions, similar to EDD of dT6, which provided (a3 - H)• , (a4 - H)•, and (a5 - H)• product 
ions.  “ECD-like” and “EDD-like” fragments from niECD-IRMPD indicate that niECD-
IRMPD may share similarities with both EDD and ECD.  Zwitterionic forms of 
protonated and deprotonated DNA have been proposed.13, 39  In this hypothesis, a 
negative charge on a positively charged oligonucleotide is likely to be stabilized by a 
nearby positive charge (“salt-bridge” effect).  Likewise, a positive charge on a negatively 
charged oligonucleotide is likely to be stabilized by a nearby negative charge.  Thus 
niECD and ECD may have similar mechanisms.  
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Table 5.1. Summary of fragments identified in niECD-IRMPD spectra of 
RNA and DNA hexamers A6, G6, C6 and U6 (T6). 
RNA 
sequence 
Fragments identified in 
niECD-IRMPD 
 
DNA 
sequence 
Fragments identified in  
niECD-IRMPD 
rA6 b1/y1 
b3/y3 
c1/x1 
c2/x2 
c3/x3 
d1/w1 
d2/w2 
d3/w3 
d4/w4 
 
 
 
 
dA6 (a2 - H)• 
(a3 - B) 
(a4 - B) 
 
c1/x1 
(c1 - B) 
c2/x2 
(c2 - B) 
(c3 - B) 
(c4 - B) 
d1/w1 
d2/w2 
d3/w3 
d4/w4 
d5/w5 
rG6  c1/x1 d1/w1 
d2/w2 
d3/w3 
 
 
 
dG6 (a2 - B) 
 
c1/x1 
c2/x2 
d1/w1 
d2/w2 
d3/w3 
d4/w4 
d5/w5 
rC6  c1/x1 
c2/x2 
d1/w1 
d2/w2 
d3/w3 
d4/w4 
 
 
 
 
dC6 (a2 - H)• 
(a3 - B) 
(a4 - B) 
(a3 + H)• 
(a5 + H)• 
c1/x1 d1/w1 
d2/w2 
d3/w3 
d4/w4 
d5/w5 
rU6   d2/w2 
d3/w3 
d4/w4 
 
 
 
dT6 (a2 + H)• 
(a2  -  H)• 
(a4 + H)• 
(a4  -  H)• 
(a5 + H)• 
c1/x1 
c2/x2 
 
d1/w1 
d2/w2 
d3/w3 
d4/w4 
d5/w5 
 
Note: Due to the symmetry of investigated RNAs and DNAs, ions labeled d could 
also be w ions, a could also be z, b could also be y, and c could also be x. 
 
5.4 Conclusions 
Here we presented electron capture by singly deprotonated RNA/DNA and 
multiply deprotonated RNA.  IR activation before or after the electron capture event, 
denoted as AI-niECD and niECD-IRMPD, respectively, provided further fragmentation.  
Fragments from niECD-IRMPD of the RNA/DNA hexamers A6, G6, C6 and U6/T6 were 
compared with EDD of the same but doubly deprotonated RNA/DNA and with ECD of 
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the same but doubly protonated RNA/DNA.  In general, niECD-IRMPD provided similar 
fragmentation patterns and fragmentation efficiencies as EDD.  However, characteristic 
“ECD-like” radical fragments also suggested similarities to ECD.  The latter similarities 
may be due to DNA/RNA zwitterionic structures in negative ion mode. 
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Chapter 6 
Gas-Phase Proton Transfer Reactions and Segmented-flow Fraction 
Collection for Improved niECD of Phosphopeptides 
 
6.1 Introduction 
Tandem mass spectrometry (MS/MS) has been well-developed and applied for 
peptide sequencing.  Vibrational activation techniques such as collision activated 
dissociation (CAD)1 are most commonly employed.  However, labile posttranslational 
modifications (PTMs) such as phosphorylation and sulfonation are frequently 
preferentially lost and localization of such PTMs can therefore be challenging.2-4  On the 
other hand, gas-phase ion-electron and ion-ion reactions such as electron capture 
dissociation (ECD)5 and electron transfer dissociation (ETD)6 are gaining popularity as 
alternatives to vibrational activation methods.  In ECD multiply charged cations react 
with electrons of low energy (< 1 eV) to form charge-reduced radical intermediates that 
further dissociate into fragments.  In ETD multiply charged cations react with radical 
anions and receive electrons to form similar charge-reduced radical intermediates as in 
ECD.  One significant reason for the rising interest in ECD/ETD is their ability to retain 
labile PTMs.6-8 
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Both ECD and ETD require multiply charged cationic precursor ions.  Generation 
of such precursor ions can be challenging for peptides with acidic PTMs such as 
phosphorylation and sulfonation.  In negative ion mode phosphorylated and sulfonated 
peptides can be detected with higher sensitivity.2, 9-12  CAD can be performed in negative 
ion mode, however,  neutral loss and internal fragmentation are usually abundant, which 
complicate spectrum interpretation.13  EDD14 and NETD15, 16 operate in negative ion 
mode but, in both techniques, backbone fragmentation efficiency is lower compared to 
ECD and ETD.  Also, both EDD and NETD require multiply charged anionic precursor 
ions.  Phosphate, water, and CO2 loss are observed in EDD and NETD spectra of 
phosphorylated peptides.16, 17  Thus a more informative MS/MS technique in negative ion 
mode is desired. 
Negative ion electron capture dissociation (niECD) is a recently developed 
MS/MS technique for dissociating peptides18 and oligonucleotides (see Chapter 5 in this 
thesis) in negative ion mode.  In niECD negatively charged precursor ions capture 
electrons with energy around 3.5-6.5 eV to form charge-increased radical intermediates.  
For peptides, niECD yields c/z-type ions with phosphate retention, analogous to ECD in 
positive ion mode.  Also, in niECD the increased charge improves sensitivity of FT-ICR 
detection because induced image current is proportional to the number of charges.19 
Despite the advantages of niECD, one current drawback is the relatively long 
irradiation time.  In recently published work the reaction time for peptide niECD was 10-
20 seconds.18  By contrast, ECD and ETD reaction times are typically in the sub-second 
range.  The long reaction time is likely due to Coulomb repulsion between precursor 
anions and electrons, thus lowering the cross section for electron capture.  Precursor ion 
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accumulation time also contributes to the total acquisition time.  Fragmentation efficiency 
in niECD is lower for doubly-charged precursor ions, compared with singly-charged 
precursors, presumably due to increased Coulomb repulsion.  In electrospray ionization 
(ESI) of peptides, higher masses tend to carry more charges.  Thus, for peptides with 
higher masses, less precursor ions at lower charge states are available for efficient niECD.  
Also, for peptides electrosprayed from a lower concentration, higher charge states are 
more abundant due to the higher relative concentration of charge carrying molecules in 
the solution.  Thus, for peptides with higher masses or at lower concentration, precursor 
accumulation time can be a significant contributor to the total acquisition time.  
Such relatively long acquisition time can be a limiting factor for coupling niECD 
online with liquid chromatography (LC).  In chromatography optimum separation and 
high peak capacity are pursued to improve detection sensitivity and the number of 
detected analytes.  However, a narrower chromatographic peak allows less time for MS 
detection.  Two possible routes can be envisioned to avoid this synchronization problem.  
One approach is to decrease the niECD acquisition time and the other is to perform 
offline LC with fraction collection that can preserve LC separation. 
Reduction of the niECD acquisition time, particularly for peptides with higher 
masses or at low concentration, may be achieved by increasing the abundance of lower 
charge state precursor ions via a proton transfer reaction (PTR).20, 21  PTRs involve gas-
phase reactions between precursor ions and reagent ions of opposite polarity in order to 
manipulate the charge state of the precursor ions.  PTRs have shown utility for reducing 
the number of precursor ion charges,22 charge-state purification,23 charge inversion,24 and 
metal addition.25   
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Nano-LC, based on sub-millimeter i.d. capillary columns, offers high 
chromatographic resolution and high detection sensitivity compared to conventional 
LC.26, 27  Online coupling of nano-LC with mass spectrometry is widely applied because 
mass spectrometry offers high sensitivity, high speed, and the capability of analyzing 
complex mixtures.28, 29  However, fraction collection and offline ESI-MS may be desired 
because samples can be stored, transferred, and analyzed with more flexibility.  
Microliter scale fractions can be collected in well-plates.30  However, smaller fraction 
volumes are needed to preserve nano-LC separation.  Fraction collection via 
compartmentalization with an immiscible phase has been implemented in capillary 
electrophoresis31 and nano-LC.32  In this technique, nano-LC eluent is collected into a 
tubing or a microfabricated channel by forming plugs separated by an immiscible oil 
from a T junction.  Collected droplets can be infused for ESI-MS with preservation of LC 
separation and at variable flow rates for optimum analysis of each plug.33, 34 
 Here we investigate how PTR prior to niECD affects the acquisition time and the 
sensitivity of niECD for phosphorylated and sulfonated peptides with higher masses or in 
low concentration.  Also, we coupled fraction collection by segmented flow to niECD. 
6.2 Experimental Section 
6.2.1 Sample Preparation 
The peptides H-SFVLNPTNIGMpSKSSQGHVTK-OH (DAM1), H-
FQpSEEQQQTEDELQDK-OH (BBC), H-TRDIYETDpYYRIK-OH (KDI1), H-
TRDIpYETDpYpYRIK-OH (KDI3), H-DLDVPIPGRFDRRVVpSVAAE-OH (PRSIIS), 
and H-DFEEIPEEsYLQ-OH (Hirudin-1, 55-65) were purchased from AnaSpec, Inc. 
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(Fremont, CA).  H-RRREEEpSEEEAA-OH and H-DRVYIHPFHL-OH  (Angiotensin I) 
were purchased from Sigma-Aldrich (St. Louis, MO) and H-DsYMGWMDF-NH2 
(CCKS) was purchased from Advanced Chemtech (Louisville, NY).  H-
TSTEPQpYQPGENL-NH2 was from Millipore (Billerica, MA) and H-KRSpYEEHIP-
OH (NPF) was purchased from GenScript (Piscataway, NJ).  Bovine milk α-casein was 
from Sigma-Aldrich (St. Louis, MO).  All chemicals were used without further 
purification.  Trypsin (Promega, Madison, WI) digestion of α-casein was performed for 
12 h at 37 °C at an enzyme/substrate ratio of 1:50.  H-VPQLEIVPNpSAEER-OH (α-
casein 121-134), H-DIGpSEpSTEDQAMEDIK-OH (α-casein 58-73) and H-
TVDMEpSTEVFTK-OH (α-casein 153-164) were subjected to MS/MS.  Peptides and 
protein digest were dissolved in 1:1 (v/v) water/acetonitrile with 0.1% formic acid.  
Acidic electrospray solution was used to mimic the typical mobile phase in RPLC.  
Samples were infused at 80 μL/h via an Apollo II (Bruker Daltonics, Billerica, MA) 
electrospray ion source. 
A mixture of BBC, NPF, and DAM1 (0.2 pmoles of each) was separated on an in-
house-made capillary C18 column at 300 nL/min provided by an ultra performance liquid 
chromatography (UPLC) pump (NanoAcquity, Waters, Milford, MA).  The 75 μm i.d. x 
10 cm column was packed with Waters dC18 3μm particles.  Mobile phases were, A: 10 
mM ammonium formate, 0.15% formic acid, B: 0.15% formic acid in methanol.  The 
solvent gradient was 0 to 70 % B in 22 min.  The nano-LC eluent entered a T junction 
into which perfluorodecalin was pumped at 150 nL/min, following a procedure developed 
by Li et al.34  This configuration generated 30 nL fractions separated by ~15 nL 
perfluorodecalin.  This segmented flow was collected into a 150 μm i.d. high purity 
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perfluoroalkoxy plus (HPFA+) tubing (Upchurch Scientific, Oak Harbor, OR).  The 
tubing with collected fractions was connected to a Pt-coated fused silica ESI emitter with 
a 5 μm i.d. tip (New Objective, Woburn, MA).  Droplets from the segmented flow were 
infused at 20-100 nL/min via an Apollo II electrospray ion source modified for nano-ESI.  
The emitter tip was at a 45° angle with respect to the inlet orifice of the mass 
spectrometer.  The tip position was manually adjusted to optimize the electrospray 
process.  A voltage of ~1300 V was applied to the tip. 
6.2.2 Mass Spectrometry 
PTR mass spectra were acquired on a 7T SolariX ESI-Q-FT-ICR mass 
spectrometer (Bruker Daltonics) equipped with an ETD module.  PTR in the external 
hexapole was performed by first accumulating precursor anions for 0.5 s to 5 s, followed 
by accumulation of protonated fluoranthene cations (203 Da) for 0.5 s to 1 s. Singly 
protonated fluoranthene cations were generated in an external chemical ionization (CI) 
source with methane as carrier gas.  niECD was performed in the ICR cell by irradiating 
reacted precursor anions with electrons from an indirectly heated hollow cathode filtered 
by a ring electrode.  The cathode bias voltage was -  3.5 to - 4.5 V and a lens located 
between the cathode and the ICR cell was at - 2.5 to - 3.5 V.  The irradiation time was 3 
to 5 s.  Spectra were processed by DataAnalysis 4.0 software (Bruker Daltonics) and 
peaks were assigned within 10 ppm error after internal calibration.  Precursor ions and 
the charge-increased radical species were used as internal calibrants. 
Online nanoESI-MS was performed on an LCQ DECA XP+ (Thermo-Finnigan, 
San Jose, CA) ion trap mass spectrometer.  niECD mass spectra of fraction-collected 
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peptides were acquired on a 7T Apex ESI-Q-FT-ICR mass spectrometer (Bruker 
Daltonics).  Precursor anions were accumulated in the external hexapole for 10 s.  niECD 
was performed with the same method as above.  The cathode bias voltage was - 6 V and 
the lens voltage was - 4.8 V with an irradiation time of 4 s. 
6.3 Results and Discussion 
6.3.1 niECD of Doubly and Singly Deprotonated Phosphopeptide BBC 
The phosphopeptide BBC (H-FQpSEEQQQTEDELQDK-OH, monoisotopic 
mass 2060.8211) was electrosprayed in negative ion mode at a concentration of 0.5 μM 
as shown in Figure 6.1. 
 
Figure 6.1.  Overlay of two negative ion mode ESI mass spectra of the phosphopeptide 
H-FQ-pS-EEQQQTEDELQDK-OH at 0.5 μM.  The red spectrum was optimized for the 
1- charge state and the blue spectrum was optimized for the 2- charge state.  Several ion 
source and ion transfer parameters were tuned to optimize detection of 2- and 1- ions, 
respectively, with the time-of-flight between the external hexapole and the ICR cell 
having the largest influence. 
 
The mass spectrometer can be tuned for optimum detection of either the 1- or 2- 
charge state of a certain peptide.  In order to make a fair comparison of the signal 
abundance of the 1- and 2- charge states of BBC, two ESI spectra were acquired from the 
130 
 
same sample but with different sets of parameters for mass spectrometric detection, each 
optimized for detecting one of these charge states.  The flight time allowed for ions to be 
transferred from the external hexapole to the ICR cell had the largest influence.  Two ESI 
spectra resulting from each of these two conditions are overlaid in Figure 6.1.  The ion 
abundance of doubly deprotonated BBC was four times higher than singly deprotonated 
BBC, following normalization to charge state.  Both the 1- and 2- ions were quadrupole 
isolated, externally accumulated in a hexapole for the same amount of time (3 s) and 
subjected to niECD in the ICR cell.  The corresponding niECD spectra of singly and 
doubly deprotonated BBC are shown in Figure 6.2. 
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Figure 6.2.  niECD of the singly (a) and doubly (b) deprotonated phosphopeptide H-
FQpSEEQQQTEDELQDK-OH.  The cathode voltage was - 4.1 V and the irradiation 
time was 4 s.  
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In the niECD spectrum of singly deprotonated BBC, the [M - H]2-• radical from 
electron capture was observed as the most abundant product ion and c/z-type ions were 
also dominant.  14 out of 30 possible c/z-type ions were detected corresponding to 
cleavage of 12 out of 15 backbone amine bonds.  Phosphate was retained on all product 
ions containing the phosphoserine residue.  Abundant c•/c’ and z’/z• ions were observed 
from hydrogen migration, a phenomenon that also has been observed in conventional 
ECD.35  In cation ECD, it has been shown that the extent of hydrogen migration is related 
to the lifetime of radical ion intermediates,36 which is affected by the amount of 
intramolecular non-covalent interactions.37  For niECD it has been proposed that 
zwitterionic structures are important for electron capture to occur.18  Within a zwitterion 
the proton may be stabilized by a negatively charged group, such as the C-terminus or 
acidic side chains.  Such salt bridges could contribute to the high degree of observed 
hydrogen transfer. Another observation was the shorter irradiation time (4 s) compared to 
the previous report18 (10-20 s).  One reason for this time improvement could be that the 
previous niECD was performed on a different instrument and, thus, electron and 
precursor ion trajectories can be different.  Another reason may be that BBC (2061 Da) is 
larger than most peptides investigated in the previous work.  More structural flexibility of 
larger peptides could enhance self-solvation of a positive charge.  Thus, larger peptides 
could form more stable zwitterionic structures that are more likely to capture electrons. 
Following electron irradiation of doubly deprotonated BBC, an [M - 2H]3-• radical 
from electron capture was observed at low abundance but no c/z type ions were detected.  
An electron detachment species, [M - 2H]-•, and a•/x-type ions were also observed.  
Coulomb repulsion between doubly negatively charged precursor ions and electrons is 
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more significant than between singly charged precursor ions and electrons.  Thus electron 
capture is less likely to occur for doubly charged anions.  Another reason for this low 
level of electron capture may be that a hexapole is used to transport ions into the ICR cell, 
thus focusing the ions into a compressed packet in both the radial and axial directions.  
The tightness of the ion packet may lower the overlap with the electron beam.  In our 
previous niECD work, a doubly charged peptide was fragmented by niECD into c/z-type 
ions.  However, that experiment was performed on a different FT-ICR instrument with a 
series of ion lenses instead of a hexapole.  Ions transported by the series of ion lenses are 
less axially focused compared with the hexapole and the overlap between ions and the 
electron beam may be larger than in the hexapole-equipped instrument.  One possible 
explanation for the observation of electron detachment and a•/x-type ions may also be 
related to the specific instrument configuration.  Electrons from the cathode travel in the 
opposite direction of the analyte ions.  Electrons with an average energy of 4 eV travel 
through the ICR cell (the trapping plates are at less than - 1 V).  The “side-kick” electrode 
pair located on the opposite side of the analyzer cell was set to -3 V and -11 V.  Thus, 
electrons may be turned around by these voltages to be reflected back into the ICR cell at 
higher than the original energy.38, 39  Such higher energy electrons could cause the 
observed EDD-type product ions.  Electron reflection should also happen in niECD of 1- 
ions.  However, the corresponding charge-reduced product ions would be neutral and thus 
cannot be detected. 
In the ESI spectrum the ion abundance of doubly deprotonated BBC was four 
times higher than the singly deprotonated form, however, niECD of singly charged BBC 
provided significantly more sequence information.  In other words, a large portion of 
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peptide anions generated by ESI could not be efficiently utilized for niECD and sequence 
analysis. 
6.3.2 PTR-assisted niECD of the Doubly Deprotonated Phosphopeptide BBC 
PTR has been utilized to reduce the charge of electrosprayed proteins.40-42  In our 
case it is desired to use PTR to convert doubly charged peptide anions to their singly 
charged form and thus improve niECD efficiency.  Doubly charged peptide anions were 
accumulated in the external hexapole and reacted with singly protonated fluoranthene 
cations.  As shown in Figure 6.3, the abundance of singly deprotonated peptide ions 
increased after PTR.  The proton transfer reaction yield was 30%, based on signal 
abundance normalized to charge state.  The optimum PTR reaction time was found to be 
1 s to maximize the abundance of 1- ions.  Longer PTR further neutralizes 1- ions and 
thus reduces their abundance.  
 
Figure 6.3.  Mass spectrum following PTR between doubly deprotonated peptide anions 
and protonated fluoranthene. 
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Reaction products were transferred to the analyzer cell for niECD experiments.  
Ions were dissociated under the same conditions as in Figure 6.2.  The corresponding 
niECD spectrum is shown in Figure 6.4. 
 
Figure 6.4.  PTR-niECD spectrum of the doubly deprotonated phosphopeptide H-
FQpSEEQQQTEDELQDK-OH.  The PTR time was 1 s, the cathode voltage was - 4.1 V 
and the irradiation time was 4 s.  
 
Similar sequence coverage was obtained in niECD of singly deprotonated H-
FQpSEEQQQTEDELQDK-OH and PTR-niECD of the doubly deprotonated form.  For 
PTR-niECD, 13 possible c/z ions were detected, corresponding to 11 backbone cleavages, 
compared to 14 c/z ions and 12 backbone cleavages in niECD alone.  z112- ions were 
unique to PTR-niECD and a c4 ion was unique to niECD.  Due to the low abundance of 
the 1- charge state following ESI of the peptide H-FQpSEEQQQTEDELQDK-OH, 5-10 
s external hexapole accumulation was required for efficient niECD of this charge state.  
By contrast, with PTR, the 2- charge state could be accumulated for only 1.5 s.  Thus, 
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PTR shortens the experiment time for this peptide while providing similar sequence 
coverage.  
In ESI, peptides at lower concentration tend to carry more charges, due to the 
relatively higher concentration of charge carrying molecules in the electrospray solution.  
Thus, niECD can be more challenging at lower concentration.  In order to compare 
niECD and PTR-niECD performance, the phosphopeptide BBC was electrosprayed at a 
concentration of 0.1 μM (compared to 0.5 μM in the previous experiments shown in 
Figures 6.1 to 6.4) to generate 1- and 2- charge states.  The niECD spectrum from the 1- 
charge state is shown in Figure 6.5(a) whereas the PTR-niECD spectrum of the 2- charge 
state is shown in Figure 6.5(b). 
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Figure 6.5.  (a) niECD of the singly deprotonated phosphopeptide H-FQ-pS-
EEQQQTEDELQDK-OH at 0.1 μM.  The spectrum is shown at 100% scale. (b) PTR-
niECD of the doubly deprotonated form of the same peptide. 
For the niECD experiment of BBC in the 1- charge state, precursor ions were 
accumulated for 5 s.  However, the abundance was so low that no fragments were 
observed.  For PTR-niECD of BBC in the 2- charge state, precursor ions were 
accumulated for the same time, resulting in detection of 10 out of 30 possible c/z ions, 
corresponding to eight out of 15 possible backbone cleavages.  It is clear that, in this case, 
PTR significantly improved the sensitivity of niECD. 
6.3.3  Effect of PTR on Sensitivity and Product Ion Yield in niECD 
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As shown above, PTR prior to niECD improved the sensitivity of niECD for the 
phosphopeptide BBC.  We investigated more peptides, mostly phosphopeptides, to 
evaluate the sensitivity improvement by PTR, as summarized in Table 6.1. 
 
Table 6.1.  Comparison of sequence coverage in the form of c/z-type fragments from 
PTR-niECD of doubly deprotonated peptides and niECD of the same peptides in their 
singly charged form.  The total acquisition time for PTR-niECD and niECD was the same 
for both charge states.  All peptides were electrosprayed at 0.1 μM.  
Based on Table 6.1, for investigated peptides heavier than 1702 Da, more 
backbone cleavages were observed when PTR was applied.  In several cases (H-
SFVLNPTNIGMpSKSSQGHVTK-OH, H-DLDVPIPGRFDRRVpSVAAE-OH, H-
FQpSEEQQQTEDELQDK-OH, H-TRDIpYETDpYpYRK-OH and H-
TRDIYETDpYYRK-OH), no backbone cleavages were observed from niECD of singly 
deprotonated peptides whereas PTR-niECD provided 27-61% sequence coverage.  For H-
SFVLNPTNIGMpSKSSQGHVTK-OH and H-DLDVPIPGRFDRRVpSVAAE-OH the 
phosphorylation sites could be precisely located.  For peptides between 1660 Da and 
1296 Da, the sequence coverage was the same in PTR-niECD and direct niECD 
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experiments.  In these cases both the 2- and 1- charge states of the electrosprayed 
peptides were abundant and PTR did not seem to improve the sequence coverage.  For 
the peptide H-KRSpYEEHIP-OH with a mass of 1238 Da, the 1- charge state was the 
major form in the ESI spectrum.  In this case PTR was not advantageous. 
One way to evaluate the duty cycle of one MS/MS technique is to compare the product 
ion yield for a certain acquisition time.  If one MS/MS technique yields more backbone 
fragments within a shorter time period it would improve the performance of LC-MS/MS.  
We compared the product ion yields for the same acquisition time between PTR-niECD 
and niECD, as shown in Figure 6.6. 
 
Figure 6.6.  Comparison of fragmentation efficiencies in non-PTR niECD and PTR-
niECD at two peptide concentrations.  (a) Peptides were electrosprayed at 0.1 μM.  (b) 
Peptides were sprayed at 0.5 μM. 
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In Figure 6.6, fragmentation efficiency is defined as the summed abundance of 
assignable c/z type ions divided by the acquisition time of a single scan.  The plotted 
fragmentation efficiency ratio is between non-PTR niECD of singly deprotonated 
peptides and PTR-niECD of the same peptides but in their doubly deprotonated form.  A 
ratio of 1 means that non-PTR niECD and PTR-niECD generate the same product ion 
abundance within the same acquisition time, as represented by the dotted line.  
In Figure 6.6a, peptides were electrosprayed at 0.1 μM.   As the peptide mass 
increases, the fragmentation efficiency ratio decreases, demonstrating that improvement 
of niECD from PTR is more significant.  For peptides heavier than ~1800 Da, product 
ions generated by niECD alone were limited and, in order to detect significant fragments 
from these peptides at 0.1 μM, PTR was necessary.  For most peptides from ~1400 to 
~1800 Da, niECD provided detectable abundance of product ions.  However, PTR-
niECD provided more.  The only exception is H-TSTEPQpYQPGENL-NH2 (1542 Da).  
One possible reason could be that the product ion abundance was very low in both niECD 
and PTR-niECD and thus the abundance ratio calculations have large error.  For the 
peptide lighter than ~1400 Da, niECD alone provided more abundant product ions than 
PTR-niECD.  
In Figure 6.6b, peptides were electrosprayed at 0.5 μM.  Similar to the case of 0.1 
μM, as the peptide mass increases, the fragmentation efficiency ratio decreases.  For most 
peptides heavier than ~1800 Da, product ions generated by niECD alone were detectable, 
while PTR-niECD provided approximately twice the abundance.  For peptides lighter 
than ~1700 Da, niECD provided more abundant product ions.  From the general trend 
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line in Figure 6.6b, PTR-niECD is more efficient for 0.5 μM peptides heavier than 
approximately 1700 Da, while, for 0.1 μM peptides, PTR-niECD is more efficient for 
peptides heavier than approximately 1500 Da.  This difference between the threshold 
masses could arise from the fact that peptides electrosprayed at lower concentration tend 
to carry more charges.  
In proteomic studies trypsin is the most commonly employed protease.  The 
length distribution of tryptic peptides was demonstrated to be centered around 13-15 
amino acid residues.43  From these numbers, the mass distribution can be estimated to be 
centered around 1445-1667 Da, based on the average mass of natural amino acids.44  As 
shown in Figure 6.6 the threshold mass for PTR-niECD to be more effective than niECD 
alone is around 1500-1700 Da, which overlaps with the center of the tryptic peptide mass 
distribution.  Thus PTR could potentially improve the fragmentation efficiency for 
roughly half of tryptic peptides in a proteomic study based on niECD, provided that 
niECD is successful.  
6.3.4. Coupling Segmented-flow Fraction Collection and niECD 
Coupling niECD to offline-nanoLC by segmented-flow fraction collection could 
potentially be advantageous over coupling to online-nanoLC because the infusion flow 
rate of the collected droplets can be lower than the nanoLC flow rate.  A lower flow rate 
allows more time for the mass spectrometer to perform niECD and signal average over 
multiple scans.  Fraction collection by segmented flow may better preserve temporal 
resolution than conventional fraction collection techniques due to the small size of each 
droplet.33, 34   
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Figure 6.7a shows the total ion chromatogram of a mixture of peptides (NPF, 
BBC and DAM1) separated by nano-LC and analyzed by online-nanoESI-MS.  The 
nano-LC flow rate was 300 nL/min.  Figure 6.7b shows the total ion chromatogram of the 
same mixture separated by nano-LC, collected by segmented flow and analyzed by 
offline-nanoESI-MS at a flow rate of 100 nL/min.  It can be seen that LC temporal 
resolution is preserved by the segmented-flow fraction collection.  
 
Figure 6.7.  Total ion chromatograms of a peptide mixture (NPF, BBC, DAM1) 
separated by nano-LC.  (a) Eluent was analyzed by online-nanoESI-MS at a flow rate of 
300 nL/min.  (b) Eluent was collected by segmented-flow fraction collection and 
analyzed by offline-nanoESI-MS at 100 nL/min.  The mass spectrometer was a Thermo-
Finnigan LCQ ion trap instrument. 
 The same mixture of peptides were separated by nanoLC, collected by 
segmented-flow fraction collection and subjected to niECD.  The infusion flow ratewas 
100 nL/min when none of the three peptides was present in the droplets.  The flow rate 
was slowed down to 20 nL/min when one of the three peptides was observed and niECD 
was performed.  Figure 6.8 shows niECD spectra of NPF, BBC and DAM1 from infusion 
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of the segmented flow into an FT-ICR mass spectrometer.
 
Figure 6.8. niECD spectra of (a) NPF, (b) BBC and (c) DAM1.  Peptides were collected 
by segmented flow fraction collection from nano-LC and infused into a nanoESI-FT-ICR 
mass spectrometer.  Spectra were signal-averaged over 4-8 scans. 
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 In the niECD spectrum of NPF, four out of eight total possible backbone 
cleavages were observed corresponding to seven out of 16 possible c/z-type ions.  In the 
niECD spectrum of BBC, nine out of 15 total possible backbone cleavages were observed 
corresponding to 10 out of 30 possible c/z-type ions.  For niECD of DAM1, 12 out of 20 
total possible backbone cleavages were observed corresponding to 13 out of 40 possible 
c/z-type ions.  In the cases of BBC and DAM1, phosphorylation sites could be directly 
located. 
6.4 Conclusion 
Peptides tend to carry more charges as their sizes increase or concentrations 
decrease.  However, niECD is more efficient for peptide anions with fewer charges.  
Precursor ion accumulation can be a significant contributor to the total acquisition time in 
an niECD experiment.  Here we demonstrated that PTR prior to niECD can decrease the 
ion accumulation time, and improve niECD sensitivity.  Among the peptides investigated, 
niECD performance of most peptides heavier than 1500-1700 Da was improved by PTR.  
For several peptides electrosprayed at 0.1 μM, niECD of the singly charged form did not 
provide any detectable fragments, while PTR-niECD of the doubly charged form 
provided 27-61% sequence coverage.  Also, we demonstrated that niECD can be coupled 
to offline nano-LC by segmented flow fraction collection. 
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Chapter 7 
Conclusions and Future Outlook 
 
Mass spectrometry has been widely studied and developed for various scientific 
areas.  Figure 7.1 illustrates the distribution of the number of journal articles related to 
mass spectrometry in ten different research areas.  Biological sciences are one of the 
major areas in which mass spectrometry is involved. 
 
Figure 7.1.  Distribution of journal articles related to mass spectrometry in ten different 
scientific areas.  The numbers were retrieved from Web of Science (Thomson Reuters, 
New York, NY), a well established database of scientific journal articles on 03/30/2011. 
As an analytical chemistry technique, mass spectrometry is one powerful tool to 
characterize peptides/proteins and nucleic acids.  For these molecules, information 
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regarding identification, quantification, structure, and interaction can possibly be 
obtained.   
This dissertation demonstrates my efforts in mass spectrometry method 
development for peptide/protein and nucleic acid analysis.  Projects are classified into 
three categories: (1) Applying existing emerging MS techniques to molecules not 
previously studied by these techniques. (2) Improvement of MS techniques. (3) Applying 
MS techniques to solve biological problems.  
7.1 Summary of Results 
First we compared non-acetylated PNA fragmentation in both positive and 
negative ion mode by CAD, IRMPD, ECD (positive ion mode only) and EDD (negative 
ion mode only).  Also, we employed double resonance to investigate the mechanism of 
water loss in CAD and IRMPD of PNAs.  For investigated MS/MS techniques in positive 
ion mode, full sequence coverage was obtained from CAD and IRMPD.  However, 
abundant water loss, neutral loss, and unassignable peaks were also observed.  Either the 
N- and C-terminus of PNA could be involved in the water loss pathway, as observed in 
double resonance experiments.  Acetylation of the N-terminus reduced facile water loss 
and the spectrum was easier to interpret.  ECD provided less backbone cleavages than 
CAD and IRMPD and also abundant neutral loss peaks.  For investigated MS/MS 
techniques in negative ion mode, full sequence coverage was also obtained in CAD and 
IRMPD but neutral loss was also observed.  However, compared with positive ion mode, 
neutral loss was of lower abundance.  Thus CAD spectra in negative ion mode were 
easier to interpret.  EDD provided limited backbone cleavages.  Overall, operating CAD 
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and IRMPD in negative ion mode, as well as acetylation of the PNA N-terminus, reduced 
the abundance of neutral loss peaks and simplified spectrum interpretation. 
Second, we investigated the characterization of the 27-mer RNA R1 and its 
complexes by top-down mass spectrometry, as well as ion mobility mass spectrometry 
(IM-MS).  Gas-phase structure and folding status of RNA R1 could be probed by IM-MS.  
More charges on the molecule seemed to correlate with a less compact gas phase 
structure, as observed from CCS measurements in IM-MS.  Competitive experiments 
revealed that ligand binding specificity was dependent on charge state and further 
confirmed the correlation between RNA R1 folding status and ligand binding.  Sequence 
coverage from AI-EDD experiments increased as the charge on R1 increased.  From AI-
EDD experiments a ligand-binding site from non-specific binding was identified from 
certain charge states.  In general, given the correlation between AI-EDD efficiency, 
binding specificity, precursor charge state, ligand amount in electrospray solution, and 
the organic solvent content, care should be taken when ESI-MS and AI-EDD are applied 
to the investigation of RNA-ligand complexes to avoid non-specific binding. 
We also extended top-down mass spectrometry of proteins to negative ion mode.  
IRMPD and AI-EDD were applied to three representative proteins.  Results were 
compared with IRMPD and AI-ECD in positive ion mode.  In general, negative ion 
IRMPD and AI-EDD provided complementary sequence information compared to 
positive ion IRMPD and AI-ECD.  However, less overall sequence coverage was seen in 
negative ion mode.  More complementary fragments were observed in negative ion mode 
for the acidic proteins β-casein and calmodulin than for the basic protein RNase B.  The 
reason for this behavior could be enhanced “salt-bridge” formation in positively charged 
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acidic proteins.  In particular, negative ion IRMPD of β-casein, with multiple 
phosphorylated sites close to each other, yielded backbone cleavages between the first 
four phosphorylated amino acids from the N-terminus.  Such cleavages, which are 
essential to precisely locate phosphorylation sites, were not observed in positive ion 
IRMPD and only partially in AI-ECD. 
A new MS/MS technique, negative ion electron capture dissociation (niECD), 
was developed in our group.  We demonstrated electron capture by singly deprotonated 
RNA/DNA and multiply charged RNA.  Activation before or after the electron capture 
event, denoted as AI-niECD and niECD-IRMPD, respectively, provided further 
fragmentation.  Fragments from niECD-IRMPD of the RNA/DNA hexamers A6, G6, C6, 
and U6/T6 were compared with EDD of the same but doubly deprotonated RNA/DNA, 
and with ECD of the same but doubly protonated RNA/DNA.  In general, niECD-
IRMPD provided similar fragmentation patterns and fragmentation efficiency as EDD.  
However, characteristic “ECD-like” radical fragments suggested similarities to ECD as 
well, supporting the proposed zwitterion mechanism for niECD. 
niECD was originally demonstrated for peptides, which tend to carry more 
charges as their sizes increase or their concentrations decrease.  However, niECD is 
generally more efficient for peptide ions with fewer charges.  Precursor ion accumulation 
time can be a significant contributor to the total acquisition time in an niECD experiment.  
We demonstrated that PTR prior to niECD can potentially decrease the ion accumulation 
time, and improve niECD sensitivity.  Among the peptides investigated, niECD 
performance for most peptides heavier than 1500-1700 Da was improved by PTR.  For 
several peptides electrosprayed at 0.1 μM, niECD of the singly charged form did not 
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provide any detectable fragments, while PTR-niECD of the doubly charged form 
provided 27-61% sequence coverage.   
7.2 Prospects for Future Work 
7.2.1 Comparison of Ionization Efficiency for Detecting Acidic Peptides in Positive 
and Negative Ion Mode 
In proteomic studies LC-MS is a widely applied technique to analyze proteins or 
proteomes after digestion by proteases such as trypsin.  LC separation prior to mass 
spectrometric analysis provides numerous advantages including, but not limited to, (1) 
separation of nonvolatile contaminants, which interfere with ESI, from the peptides to be 
analyzed; (2) enrichment of each peptide to improve detection sensitivity; (3) reduction 
of sample complexity and ion suppression.  Reverse-phase chromatography is a 
commonly employed technique to separate peptides based on hydrophobicity1 in which 
acids are usually added to the mobile phase to improve the separation,2  ESI-MS coupled 
with LC is commonly operated in positive ion mode as the LC eluent is acidified.3  
Tryptic peptides contain at least two basic groups, one at the N-terminus and the other at 
the C-terminal lysine or arginine side chain.  Thus, theoretically, most tryptic peptides in 
acidified solution should ionize well in positive ion electrospray ionization.  Peptides can 
also be ionized in negative ion mode, which should be particularly favorable for peptides 
containing carboxylic acid groups at their C-termini and acidic side chains such as 
aspartic and glutamic acid.  Also, PTMs such as phosphorylation and sulfonation can 
dramatically decrease the pI of a peptide.4  Acidic peptides show improved ionization 
efficiency in negative ion mode.  For example, it has been demonstrated that 
phosphorylated peptides from a tryptic digest of a phosphorylated protein were detected 
with higher sensitivity in negative ion mode.5  However, systematic comparison of 
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ionization efficiency for acidic and basic peptides in LC-MS is less well addressed.  Such 
a comparison may provide guidance to the analysis of acidic peptides, particularly in 
phospho-proteomics where phosphorylated peptides are the analytes of major interest. 
In phospho-proteomics, phosphorylated peptides are generally of low abundance 
compared to non-phosphorylated peptides.6  During ESI in positive ion mode, regular 
peptides compete with phosphopeptides for available protons in the solution.  The 
ionization of acidic phosphorylated peptides may thus be suppressed by other more basic 
peptides,6 which have higher proton affinity.7  Figure 7.2a shows extracted ion 
chromatograms for the peptide H-TPQKPSQNLVPVTPSTTK-OH in unphosphorylated 
(0p),  singly (1p), and doubly (2p) phosphorylated forms.  These peptides were from a 
protein digest, separated on a 1 mm (i.d.) C18 RPLC column with an acidified mobile 
phase, electrosprayed at 300 μL/h and detected in positive and negative ion mode, 
respectively.  MS signal for the non-phosphorylated form was higher in positive ion 
mode whereas MS signal for the singly phosphorylated form was similar in positive and 
negative ion mode.  MS signal for the doubly phosphorylated form was higher in 
negative ion mode.  
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Figure 7.2.  Comparison of extracted ion chromatograms for the peptide H-
TPQKPSQNLVPVTPSTTK-OH in unphosphorylated (0p), singly (1p), and doubly (2p) 
phosphorylated forms in positive and negative ion mode.  ESI flow rates were (a) 300 
μL/h and (b) 3000 μL/h. 
Figure 7.2 shows extracted ion chromatograms of the same peptides under the 
same chromatographic conditions, except for the flow rate, which differs by a factor of 10.  
In this case MS signal of doubly phosphorylated peptides were still smaller in positive 
ion mode.  However, the difference between positive and negative ion mode was smaller, 
compared to a flow rate of 300 μL/h.  In our experiment, the Apollo II ESI source was 
optimized for a flow rate around 0.1 mL/h.  At such flow rate phosphorylated peptides 
from a tryptic digest of a phosphorylated protein were detected with higher sensitivity in 
negative ion mode.5  However the flow rate during online LC-MS experiments was 3 
mL/h.  At such relatively high flow rate, the total ion current may saturate the ESI source 
in both positive and negative ion mode.  Thus the total numbers of ionized peptides in 
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both modes may be capped by the capability of the ESI source and a difference can 
therefore be more difficult to observe.   
The flow rate manipulation was achieved by splitting the eluent before the ESI 
spray tip.  Under typical RPLC conditions, the optimum flow rate for a 1 mm (i.d.) RPLC 
column is around 3000 μL/h.  The Apollo II ESI source on our mass spectrometer was 
optimized for direct infusion of samples, which typically operates at the 100 μL/h range.  
LC flow splitting is commonly achieved by T-shaped splitters.  The split ratio is 
calibrated by the i.d. and length of two pieces of outlet tubing.  However, in practice, we 
found that, in the flow rate range we operate our LC, gravity also plays an important role 
in controlling the flow rate. 
  
Figure 7.3.  Systematic diagram of the principle for fine-tuning LC-MS flow rate.  
Devices are not accurate to scale. 
Figure 7.3 shows a systematic diagram of a method for fine-tuning LC-MS flow 
rate.  LC eluent is split by a T-junction from which one portion is transferred to the ESI 
source.  The other portion is transferred to waste or fraction collection.  All pieces of 
tubing are of the same size.  By adjusting the vertical distance between the electrospray 
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tip and the outlet of the waste line the flow rate into the ESI source can be controlled.  
300 μL/h as shown in Figure 7.2a was achieved when the vertical distance was 50 cm.  
With this splitting approach we could investigate the correlation between ion 
suppression and flow rate.  Then we could systematically compare the ionization 
efficiency of acidic peptides in positive and negative ion mode.  Also we could obtain 
improved understanding of which flow rate range ion suppression for acidic peptides is 
more significant. 
7.2.2 niECD of Proteins and Larger RNAs  
niECD was first demonstrated for singly and doubly charged peptides.8  One 
significance of niECD is that it provides opportunities to dissociate peptide anions with 
acidic labile PTMs, such as phosphorylation and sulfonation, into backbone fragments 
with PTMs retained.  The modification site can be directly located and spectra may be 
simpler to interpret than commonly applied vibrational activation techniques such as 
CAD and IRMPD, in which labile PTMs are frequently lost.  ECD9 and ETD10 have been 
shown to preserve labile PTMs such as phosphorylation,11, 12 sulfonation,13 and 
glycosylation.14-16  However, ECD and ETD require multiply positively charged ions and 
only operate in positive ion mode.  Due to ion suppression, detection of acidic peptides 
may be less sensitive in positive ion mode than negative ion mode.  Thus niECD 
combines certain advantages of ECD, ETD and negative ion detection and may be 
beneficial for PTM detection and localization. 
ECD9 and ETD17 have been shown to have the ability to effectively dissociate 
intact protein cations in the gas phase.  EDD18 has been shown to fragment protein anions.  
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However the sequence coverage in EDD was not as extensive as in ECD or ETD.  Until 
now niECD has been primarily applied to peptides up to 2.3 kDa with backbone 
cleavages observed.  It would be beneficial to investigate niECD for protein anions.  If 
niECD could be developed to dissociate intact proteins it would be possible to directly 
localize labile PTMs, similar to ECD and ETD, while detecting acidic proteins in 
negative ion mode at higher sensitivity. 
 
Figure 7.4.  AI-niECD of ubiquitin with 5 negative charges.  Precursor ions were 
irradiated with an IR laser at 12.5 W for 0.3 s, then with electrons for 5 s.  The cathode 
voltage was set to - 10 V. 
Figure 7.4 shows preliminary results for AI-niECD of ubiquitin (8.5 kDa) 5- 
anions.  Major product ions are the radicals formed from electron capture.  No backbone 
cleavages are observed.  However, only one charge state of ubiquitin was investigated.  It 
has been shown that fragmentation efficiency in ECD,19 ETD20 and EDD18 is affected by 
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precursor ion charge state.  Also, a denaturing step prior to ESI may unfold the protein 
and facilitate fragmentation.18  Investigation of more charge states and sample 
preparation procedures may be valuable future work.  
In Chapter 5 it was demonstrated that AI-niECD of DNA/RNA hexamers 
provided “ECD-like” and “EDD-like” fragments.  An 8.4 kDa 27-mer RNA (5’-
GGCGUCACACCUUCGGGUGAAGUCGCC-3’) was demonstrated to capture 
electrons as well.  It may be valuable to investigate AI-niECD of larger RNAs such as 
this 27-mer.  Similar to AI-niECD of proteins, investigation of more charge states and 
sample preparation procedures may be helpful in the future.  In Chapter 3 it was 
demonstrated that higher ligand binding specificity was favored at lower precursor ion 
charge states, which did not undergo efficient EDD.  niECD, on the other hand, favors 
lower charge states, thus the latter technique may be suitable for specifically bound RNA-
ligand complexes. 
7.3 Bibliography 
(1) Chen, H.; Horvath, C. J. Chromatogr. A 1995, 705, 3-20. 
(2) Mant, C. T.; Hodges, R. S. In High-performance liquid chromatography of 
peptides and proteins: Separation, analysis, and conformation Mant, C. T., 
Hodges, R. S., Eds.; CRC Press: Boca Raton, Florida, 1991, pp 327–341. 
(3) Shi, Y.; Xiang, R.; Horvath, C.; Wilkins, J. A. J. Chromatogr. A 2004, 1053, 27-
36. 
(4) Gauci, S.; van Breukelen, B.; Lemeer, S. M.; Krijgsveld, J.; Heck, A. J. R. 
Proteomics 2008, 8, 4898-4906. 
(5) Kweon, H. K.; Hakansson, K. Anal. Chem. 2006, 78, 1743-1749. 
(6) Mann, M.; Ong, S. E.; Gronborg, M.; Steen, H.; Jensen, O. N.; Pandey, A. Trends 
Biotechnol. 2002, 20, 261-268. 
159 
 
(7) Garcia, M. C. J. Chromatogr. B 2005, 825, 111-123. 
(8) Yoo, H. J.; Wang, N.; Zhuang, S.; Song, H.; Hakansson, K. J. Am. Chem. Soc. 
2011, 133, 16790-16793. 
(9) Zubarev, R. A.; Kelleher, N. L.; McLafferty, F. W. J. Am. Chem. Soc. 1998, 120, 
3265-3266. 
(10) Syka, J. E. P.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt, D. F. Proc. 
Natl. Acad. Sci. U. S. A. 2004, 101, 9528-9533. 
(11) Stensballe, A.; Jensen, O. N.; Olsen, J. V.; Haselmann, K. F.; Zubarev, R. A. 
Rapid Commun. Mass Spectrom. 2000, 14, 1793-1800. 
(12) Shi, S. D. H.; Hemling, M. E.; Carr, S. A.; Horn, D. M.; Lindh, I.; McLafferty, F. 
W. Anal. Chem. 2001, 73, 19-22. 
(13) Kelleher, R. L.; Zubarev, R. A.; Bush, K.; Furie, B.; Furie, B. C.; McLafferty, F. 
W.; Walsh, C. T. Anal. Chem. 1999, 71, 4250-4253. 
(14) Mirgorodskaya, E.; Roepstorff, P.; Zubarev, R. A. Anal. Chem. 1999, 71, 4431-
4436. 
(15) Hakansson, K.; Cooper, H. J.; Emmett, M. R.; Costello, C. E.; Marshall, A. G.; 
Nilsson, C. L. Anal. Chem. 2001, 73, 4530-4536. 
(16) Haselmann, K. F.; Budnik, B. A.; Olsen, J. V.; Nielsen, M. L.; Reis, C. A.; 
Clausen, H.; Johnsen, A. H.; Zubarev, R. A. Anal. Chem. 2001, 73, 2998-3005. 
(17) Coon, J. J.; Ueberheide, B.; Syka, J. E. P.; Dryhurst, D. D.; Ausio, J.; 
Shabanowitz, J.; Hunt, D. F. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 9463-9468. 
(18) Ganisl, B.; Valovka, T.; Hartl, M.; Taucher, M.; Bister, K.; Breuker, K. Chem. 
Eur. J. 2011, 17, 4460-4469. 
(19) Kalli, A.; Hakansson, K. J. Proteome. Res. 2008, 7, 2834-2844. 
(20) Good, D. M.; Wirtala, M.; McAlister, G. C.; Coon, J. J. Mol. Cell. Proteomics 
2007, 6, 1942-1951. 
 
 
160 
 
Appendix 
Quantitative Investigation of the Degree of Phosphorylation on the 
Yeast Protein Sic1 
 
A.1  Introduction 
Sic1 is one of the important regulatory proteins controlling the yeast cell cycle.1  
The level of phosphorylation on this protein serves as a “switch” for the yeast cell to 
enter from G1 phase to S phase.  As yeast cells enter G1 phase, a B-type cyclin, Cln-
Cdc28 kinases, is activated and phosphorylate Sic1.  Multiply phosphorylated Sic1  is 
targeted by the SCFCdc4 ubiquitin ligase complex for ubiquitination and subsequent 
degradation.1  Upon degradation of Sic1, Clb5/6-Cdc28 is no longer inhibited,2-5 thus 
stimulating DNA replication.  This regulatory mechanism is illustrated in Figure A.1.
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Figure A.1.  Scheme of Sic1 regulatory activity in the cell cycle of S. cerevisiae. 
Adapted from Varedi et al.6  
 
Establishing a model to simulate the phosphorylation/dephosphorylation process 
of Sic1 may facilitate understanding of the regulatory activity of Sic1.  Varedi, et al. 
developed mathematical models to simulate the steady-state binding curves of Sic1-Cdc4 
as well as Sic1 phosphorylation/dephosphorylation/binding.6  Experimental determination 
of several parameters in the phosphorylation kinetics is crucial to evaluate these models.  
Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) coupled with 
high performance liquid chromatography (HPLC) can provide high mass accuracy and 
high throughput for quantification of phosphopeptides in kinetic studies.  With mass 
spectrometry it is also possible to determine the overall phosphorylation state at the intact 
protein level.  
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Absolute quantification of peptides by mass spectrometry has been widely 
explored.  Quantification based on extracted ion chromatograms (EICs) is one of the most 
common approaches.  In HPLC-ESI-MS experiments, the MS signal abundance from 
targeted peptides is summed over the elution time.  However, due to variance in 
ionization efficiency and ion suppression, ion abundance alone can be inaccurate and 
irreproducible for quantifying peptides across different samples or for comparing 
different peptides.  Abundant non-changing peptides in the LC-MS runs could serve as 
“landmark” or “background”.7  After normalization to the abundances of the landmark 
peptides, run-to-run variation can be reduced.  One example is the investigation of 
phosphorylation response.  Under the assumption that the total amount of the 
phosphorylated peptide of interest and its non-phosphorylated form is constant during the 
phosphorylation time course, ionization efficiency can be compared between the two 
forms and absolute quantification of stoichiometry can be achieved.8  However, to 
achieve absolute quantification, spiking of reference materials is  required.  The chemical 
identity of the reference material should be similar to the peptides of interest, to reduce 
ion suppression and ionization efficiency variance.  Isotopic labeling is one common 
technique to introduce appropriate standards.9  Isotopically labeled peptides with the 
same amino acid sequence as peptides of interest are chemically virtually identical but 
have different mass.  However, isotopic labeling requires isotope-incorporated reagents 
or peptides.  Other reference materials such as valine-leucine substituted standard 
peptides are more affordable and feasible.10  Valine-leucine substituted standard peptides 
provide a 14 Da mass shift, which may reduce the probability of overlapping isotopic 
distributions. 
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Here we demonstrate absolute quantification of mutant Sic1 phosphorylation with 
valine-leucine substituted standard peptides.  Also, we monitored steady-state 
phosphorylation response of wild type Sic1 and mutated Sic1 with various total available 
sites for phosphorylation with top-down mass spectrometry. 
A.2. Experimental Section 
Sic1 protein preparation and phosphorylation reactions were described 
elsewhere.6  In short, wild-type and mutated His-tagged S. cerevisiae Sic1 proteins were 
expressed in E. coli and purified with nickel-NTA columns (Qiagen).  Cln2-Cdc28 kinase 
was expressed in Hi5 cells at the Protein Expression Center of Cal Tech.11  The Cln2-
Cdc28 kinase was purified using glutathione-sepharose beads (GE Healthcare).  All 
phosphorylation reactions were performed in kinase buffer (Cell Signaling) with ATP 
(Cell Signaling) at 30 °C for various times for dynamic studies or three hours to reach 
steady state.  
In the study of phosphorylation dynamics, phosphorylated Sic1 proteins were 
digested by trypsin (Promega).  Valine-leucine substituted standard peptides (GenScript) 
were phosphorylated by Cln2-Cdc28.  Phosphorylated and non-phosphorylated forms 
were separated by an Agilent Zorbax XBD C8 reverse phase column and quantified by 
UV absorbance at 214 nm.  Mixtures of phosphorylated and non-phosphorylated forms 
were spiked into Sic1 tryptic digests as internal standards.  Sic1 tryptic digest was 
subjected to LC-MS analysis.  HPLC was performed by an Agilent 1100 series system 
(Agilent Technologies) on a Phenomenex Synergi Hydro reverse phase C18 column (1.0 
x 15 mm, Phenomenex) at a flow rate of 0.05 mL/min.  The gradient was solvent B 
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(acetonitrile with 0.1% formic acid) ramping from 2% to 60% over 60 min.  Solvent A 
was water with 0.1% formic acid.  The HPLC eluent was directly introduced online to a 
Bruker 7-T Apex-Q ESI-FT-ICR mass spectrometer (Bruker Daltonics) operating in 
positive or negative ion mode.  LC-MS data were acquired by Hystar and ApexControl 
software (Bruker Daltonics).  Extracted ion chromatograms (EICs) were calculated based 
on the accurate masses of peptides of interest and a 20 ppm error window.  This relatively 
high error tolerance was used due to the variability in peptide abundance and thus number 
of ions in the ICR cell.  In separate LC runs, fractions were also collected every 1 min 
and infused into a Bruker 7-T SolariX ESI-Q-FT-ICR mass spectrometer operating in 
positive ion mode for electron capture dissociation (ECD).  ECD experiments were 
performed in the ICR cell by irradiating precursor ions with electrons for 0.9 s.  The 
cathode bias voltage was - 0.9 V and thelens voltage was set to 0.5-1 V. 
In the study of steady-state phosphorylation response, phosphorylated proteins 
were purified with an Agilent Zorbax XBD C8 reverse phase column.  The fractions 
containing proteins were concentrated and reconstituted in 1:1 (v/v) water/acetonitrile 
with 0:1% formic acid for positive ion mode ESI.  Samples were electrosprayed via an 
Apollo II (Bruker Daltonics) electrospray source.  Mass spectra were acquired on a 
Bruker 7-T SolariX ESI-Q-FT-ICR mass spectrometer in broad band mode.  Spectra were 
processed by DataAnalysis software (version 4.0, Bruker Daltonics). 
A.3. Results and Discussion 
A.3.1. Comparison of Ionization Efficiency of Sic1 Peptides in Positive and Negative 
Ion Mode 
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In proteomics RPLC-MS is almost exclusively operated in positive ion mode.  
First, acidic ion pairing reagents are commonly added to the mobile phase to improve 
chromatographic resolution.12, 13  Widely used acids include trifluoroacetic acid, acetic 
acid, and formic acid.  Thus peptides are likely more protonated than deprotonated and 
show higher detection sensitivity in positive ion mode.  Second, trypsin is one of the most 
common proteases due to its high efficiency and specificity.  Tryptic peptides contain at 
least two basic groups: one at the N-terminus and the other one at the C-terminal lysine or 
arginine side chains.  However, the pKa of phosphorylated amino acid side chains can be 
lower than 1.514 and thus phosphate groups can still be deprotonated in acidified mobile 
phase.  For example, for water with 0.1% (v/v) formic acid the pH is 2.7.  The acidity of 
phosphate groups can dramatically decrease the pI of peptides.15  Thus, the ionization of 
acidic phosphorylated peptides may be suppressed by other more basic peptides,16, 17 
which have higher overall proton affinity.18  It has been demonstrated that 
phosphorylated peptides from a tryptic digest of a phosphorylated protein were detected 
with higher sensitivity in negative ion mode.19  We compared the ionization efficiency in 
positive and negative ion mode to ensure the phosphorylated peptides from Sic1 protein 
provided more signal intensity in negative ion mode.  It has been demonstrated that nine 
phosphorylation sites on Sic1 are responsible for the regulatory activity.1  These nine 
sites are T2, T5, T33, T45, S69, S76, S80, T173, and S191.  In a Sic1 tryptic digest, three 
peptides contain two proposed phosphorylation sites each and three peptides contain one 
site each. 
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Figure A.2.  Comparison of extracted ion chromatograms for selected tryptic peptides 
from the protein Sic1 in positive and negative ion mode.  Sic1 was phosphorylated to 
maximum extent.  Selected peptides contained phosphorylation sites as proposed.1 
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Figure A.2. illustrates the comparison of selected tryptic peptides from Sic1 in 
positive and negative ion mode.  For H-NAPLLAPPNSNMGMTSPFNGLTSPQR-OH 
(residues 54-79 in Sic1) and HNWNNNSPK-OH (Sic1 186-193), ion abundance for all 
phosphorylated forms was higher in negative ion mode compared with positive ion mode.  
For H-MHHHHHHSSGVDLGTENLYFQSNATPSTPPR-OH (Sic1 His6-1-8) ion 
abundance of the doubly phosphorylated form was higher in negative ion mode than in 
positive ion mode, while ion abundances of non- and singly phosphorylated forms were 
similar.  For H-SPFPK-OH (Sic1 80-84), H-DVPGTPSDK-OH (Sic1 167-176) and H-
TPQKPSQNLVPVTPSTTK-OH (Sic1 33-50), ion abundance in negative ion mode was 
not significantly higher than in positive ion mode.  The observation that not all 
phosphorylated peptides showed higher ion abundance in negative ion mode may be due 
to the following reasons: First, in our experiment, the Apollo II ESI source was optimized 
for a flow rate around 0.1 mL/h.  At such flow rate phosphorylated peptides from a 
tryptic digest of a phosphorylated protein were detected with higher sensitivity in 
negative ion mode.19  However the flow rate during online LC-MS experiments was 3 
mL/h.  At such relatively high flow rate the total ion current may saturate the ESI source 
in both positive and negative ion mode.  Thus the total numbers of ionized peptides in 
both modes may be capped by the capability of the ESI source and a difference can 
therefore not be observed.  Second, ion suppression experienced by one peptide is 
affected by the abundance of other peptides.  H-SPFPK-OH, H-DVPGTPSDK-OH and 
H-TPQKPSQNLVPVTPSTTK-OH were among the most abundant peptides in their 
respective fractions.  Thus they may experience less ion suppression. 
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In general, ion abundances of phosphorylated peptides are equal or higher in 
negative ion mode compared with positive ion mode.  The doubly phosphorylated form 
of H-MHHHHHHSSGVDLGTENLYFQSNATPSTPPR-OH was only detected in 
negative ion mode.  Non-phosphorylated forms were observed in both modes.  Thus 
negative ion mode was selected for subsequent analysis. 
A.3.2. Validation of Valine-Leucine Substituted Standard Peptides 
Valine and leucine residues differ by one methyl group.  Because the ionization 
efficiency of peptides often depend on their structure, an ideal standard peptide should 
have the same structure as the analyte.  Incorporation of isotopes minimizes the impact 
on peptide structure.  On the other hand, we propose that valine-leucine substitution 
introduces or removes only one methyl group and may therefore have a small impact as 
well.  However, validation is required to confirm the correlation between valine-leucine 
substituted standard peptides and peptides to quantify. 
To test our hypothesis, we investigated a peptide from wild type Sic1 containing 
two possible phosphorylation sites, H-TPQKPSQNLVPVTPSTTK-OH and its reference 
peptide H-TPQKPSQNLLPVTPSTTK-OH (Sic1 33-50-V42L) with one valine 
substituted by leucine.  To mimic the background interference from other Sic1 peptides, a 
Sic1-2p mutant tryptic digest was used.  In this mutant seven out of nine possible 
phosphorylation sites in Sic1 wild type were mutated to alanine.  In Sic1-2p mutant 
TPQKPSQNLVPVTPSTTK was modified to APQKPSQNLVPVTPSTTK 
(corresponding to the peptide Sic1 33-50-T33A).  10 pmoles of H-
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TPQKPSQNLVPVTPSTTK-OH and H-TPQKPSQNLLPVTPSTTK-OH were mixed 
and spiked into 15 pmoles of Sic1-2p digest and subjected to LC-MS analysis. 
 
Figure A.3.  Comparison of EICs for H-TPQKPSQNLVPVTPSTTK-OH and its valine-
leucine substituted reference peptide H-TPQKPSQNLLPVTPSTTK-OH.  10 pmoles of 
H-TPQKPSQNLVPVTPSTTK-OH and TPQKPSQNLLPVTPSTTK were mixed and 
spiked into 15 pmoles of Sic1-2p digest.  Sic1-2p was phosphorylated to maximum extent. 
 
Figure A.3. shows the comparison of EICs of H-TPQKPSQNLVPVTPSTTK-OH 
and its valine-leucine substituted reference peptide H-TPQKPSQNLLPVTPSTTK-OH.  
Peak areas of both peptides are similar (104% ± 10%).  Similar experiments were 
performed without the Sic1-2p tryptic digest.  Peak areas for both peptides were similar 
(101% ± 11%) in those spectra as well.  It thus appears that valine-leucine substitution is 
an acceptable method to generate reference peptides. 
 A.3.3. Investigation of Phosphorylation Kinetics of Sic1 
In Sic1-2p mutant seven serine or threonine residues were mutated to alanine 
except for T45 and S76.  We used the Sic1-2p mutant to develop an LC-MS work flow.  
Phosphorylation kinetics could be measured by monitoring the concentrations of H-
APQKPSQNLVPVTPSTTK-OH (Sic1 33-50-T33A) and H-
NAPLLAPPNSNMGMTAPFNGLTSPQR-OH (Sic1 54-79-S69A) following 
phosphorylation of  Sic1-2p for different lengths of time.  The corresponding reference 
170 
 
peptides spiked into the Sic1-2p tryptic digest were H-APQKPSQNLLPVTPSTTK-OH 
(Sic1 33-50-T33A-V42L) and H-NAPVLAPPNSNMGMTAPFNGLTSPQR-OH (Sic1 
54-79-S69A-L57V) as well as their singly phosphorylated forms. 
 
Figure A.4.  Phosphorylation kinetics of T45 (left) and S76 (right) in a Sic1-2p mutant.  
Concentrations were calculated by normalizing EIC peak areas of 33-50-T33A and 54-
79-S69A to 33-50-T33A-V42L and 54-79-S69A-L57V. 
 
Figure A.4 shows phosphorylation kinetics of T45 and S76 in the Sic1-2p mutant.  
Concentrations were calculated by normalizing EIC peak areas of 33-50-T33A and 54-
79-S69A to 33-50-T33A-V42L and 54-79-S69A-L57V, respectively.  Both non-
phosphorylated and singly phosphorylated forms of 33-50-T33A and 54-79-S69A were 
quantified.  Phosphorylation on S76 was observed to be faster than on T45.  It has been 
demonstrated that the cyclin-B kinase Cdc2 strongly prefers to phosphorylate serine in a 
SPXR motif.20  S76 in 54-79-S69A is contained in an SPQR motif and could be preferred 
for phosphorylation by Cdc28, which also belongs to the cyclin-B kinase family.  T45 is 
not contained in such a motif.  On the other hand, it has been shown that T45 contributes 
more than S76 to Sic1 in vivo instability, inferring that T45 contributes more for Cdc4 
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recognition.1  If T45 is both preferred for phosphorylation and recognition for 
ubiquitination, its regulatory activity would primarily be controlled by T45 rather than by 
multiple phosphorylated sites, which were demonstrated to participate in the regulatory 
activity. 
Another observation was that the total peptide concentration (0p + 1p form) 
decreased over the reaction time.  There are four other serine and threonine residues in 
the APQKPSQNLVPVTPSTTK peptide and three in the 
NAPLLAPPNSNMGMTAPFNGLTSPQR peptide.  Even though T45 and S76 are 
preferred to be phosphorylated by Cln-Cdc28, it is possible that other sites could be 
phosphorylated as well.  Phosphorylation at more than one site per peptide would cause 
the total peptide concentration to decrease over the phosphorylation time as we only 
monitored the 0p and 1p forms.  Further experiments are required for confirmation of this 
hypothesis. 
In a wild type Sic1 tryptic digest, three peptides contain two proposed 
phosphorylation sites.  Following Sic1 phosphorylationi to maximum extent, the protein 
was digested and separated by RPLC.  We collected singly phosphorylated H-
SNATPSTPPR-OH (Sic1 1-8 after removal of the His6 tag by TEV protease) and H-
TPQKPSQNLVPVTPSTTK-OH (Sic1 30-50) from the LC separation and performed 
electron capture dissociation (ECD) to localize the phosphorylation sites.  For H-
SNATPSTPPR-OH, the phosphorylation site was localized to T5  T2 was not 
phosphorylated.  For H-TPQKPSQNLVPVTPSTTK-OH, phosphorylation on both T33 
and T45 was observed:  c3’, c5’, c6’, c7’, c8’, c9’, c11’, c12’, z6•, z10•,z11•, and z12• ions were 
observed in forms with and without phosphate.  From this product ion list, the sum of c’ 
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ions without phosphate and z• ions with phosphate should roughly represent the 
abundance of T45 phosphorylation whereas the sum of  c’ ions with phosphate and z• 
ions without phosphate should roughly represent the abundance of T33 phosphorylation.  
The ratio between the two summed abundances is 0.96, which indicates that the 
phosphorylation level on T45 and T33 is similar. 
A.3.4. Investigation of Distribution of Phosphorylation States on Sic1 wild type and 
Mutants 
By top-down mass spectrometry we monitored steady-state phosphorylation 
response of wild type Sic1 and mutated Sic1 with various total available sites for 
phosphorylation.  Wild type and mutated Sic1 proteins were incubated with various 
amounts of Cln-Cdc28 for three hours. 
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Figure A.5.  Distribution of Sic1 phosphoforms obtained from top down mass 
spectrometry.  Mass spectra show the relative distribution of phosphoforms at various 
levels of Cln-Cdc28 in wild-type Sic1 (A),  Sic1-5p (B), Sic1-6p(C), and Sic1-7p (D).  
Insets show the binding affinity of Sic1 protein to Cdc4 as a function of Cln-Cdc28 
amount used to phosphorylate Sic1.6 
 
Figure A.5 shows the distribution of Sic1 phosphoforms after phosphorylation by 
various amounts of Cln-Cdc28.  As the amount of Cln-Cdc28 increased, Sic1 proteins 
with more phosphates were observed.  The trend was consistent with the trend of Sic1 
binding affinity to Cdc4, which was quantified by immunoblotting with a C-terminal Sic1 
antibody.  This trend indicates that the degree of Sic 1 phosphorylation is correlated with 
binding affinity to Cdc4 and subsequent degradation.  When Sic1 was phosphorylated on 
less than four sites (Figure A.5(A)), binding affinity of Sic1 to Cdc4 was low, which 
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indicates less subsequent degradation and initiation of DNA replication.  When Sic1 was 
phosphorylated on four to six sites, binding affinity of Sic1 to Cdc4 increased 
dramatically and when Sic1 was phosphorylated to the maximum extent the binding 
affinity was at a maximum.  This correlation may indicate that the appearance of Sic1 
phosphorylated on six sites is crucial in the mechanism of Sic1 regulatory function.  It 
should be noted that Sic1 with ten phosphates was observed, which could be due to 
phosphorylation of sites other than the proposed SP or TP motifs.  The latter observation 
may correlate with the observation that the sum of non-phosphorylated and singly 
phosphorylated peptide decreased along the reaction course, as mentioned in the previous 
section.  
A.4. Conclusions 
Here we demonstrated method development for quantitative investigation of the 
degree of phosphorylation on Sic1.  LC-MS with valine-leucine substituted peptides was 
developed to quantitatively study the phosphorylation kinetics of a Sic1 2p mutant.  ECD 
was applied to confirm three phosphorylation sites and semi-quantitatively compare the 
phosphorylation preference between two pairs of possible phosphorylation sites.  Intact 
Sic1 proteins were also investigated without protease digestion.  Phosphoform 
distributions combined with the binding affinity of Sic1 to Cdc4 revealed that the number 
of phosphates correlates with the mechanism of Sic1 regulatory activity.  The developed 
methods will be applied in further investigations of Sic1 functionality. 
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